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SUMMARY 
The following work describes the synthesis, 
properties and biological evaluation of adamantane 
analogues of tetrodotoxin. Studies toward the 
preparation of perhydropurine analogues of saxitoxin 
are also described. 
2-Aminotetrahydroadamantano[2,1-d]pyrimidine 
sulphate was prepared by cyclization of l-aminomethyl-
adamantan-2-ylamine with §-methyl-iso-thiouronium 
sulphate . 2-Aminomethyl-2-hydroxyadamantan-l-ylamine, 
on the other hand, afforded 5-hydroxytetrahydro-
adamantano[l,2-d]pyrimidin-2-iminium bromide 
when treated with cyanogen bromide, but failed to 
cyclize with §-methyl-iso-thiouronium sulphate, 
guanidine hydrochloride or cyanamide. 2-0xoadamantane-
1-carbonylchloride, prepared from bicyclo[3.3.l]nonane-
3a,7a-dicarboxylic acid and thionyl chloride, was the 
common intermediate in the synthesis of the adamantano 
[2,1- d ] and [1,2- d ]pyrimidines and related compounds. 
The chemical shifts of bridgehead adamantane · 
protons exhibited a consistent additivity effect, which 
proved to be useful in the interpretation of the p.m.r. 
spectra of 1,2-disubstituted adamantanes. 
The photochemical syntheses of 1,2-disubstituted 
adamantanes were investigated, but were found to be 
unsuitable for the preparation of adamantanopyrimidines. 
• 
Adarnantano[2,1-d]oxazol l din-2-one, prepared by the 
photolysis of adamantan-2-ylcarbonyl azide, was also 
prepared from l-aminoadarnantan-2-ol with phosgene and 
base. This independent synthesis afforded conclusive 
proof of the structure of the photochemical product. 
In order to prepare 4-substituted 2,8-dioxo- and 
diimino-perhydropurines, the fusion of 5-substituted 
4-aminoimidazol-2(3H)-ones with nitroacetic acid was 
investigated. The only detectable reactions were 
hydrolytic in nature; for example, 4-aminoirnidazol-
2(3H)-one gave only a-ureidoacetamide by fission of 
the C-4-N-3 bond in the presence of moisture. Nitro-
acetic acid failed to react with a number of other 
enamines, including 2-amino-l-ethoxycarbonylcyclopent-
1-ene and 2-amino-1-cyanocyclopent-l-ene, hydrolytic 
reactions again predominated. 
A preliminary investigation of the toxicity 
(M.L.D. values in mice) of 2-iminoadamantanopyrimidine 
analogues of tetrodotoxin was carried out. These 
compounds possessed some of the biological properties 
of the natural toxin, but were much less active. The 
2-oxoadarnantanopyrimidines, on the other hand, had a 
different mode of action and were found to possess 
local anaesthetic and analgesic properties. The 
toxicity of a limited number of precursors to saxitoxin 
analogues were examined, and found to be relatively 
inactive. 
For Rosette. 
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PAR'l' l 
GENERAL INTRODUCTION 
Tetrodotoxin and saxitoxin are among the most 
potent, non-protein neurotoxins known. Both have a 
minimum lethal dose of ~Bµg/kg in mice, and are thus 
considerably more toxic than sodium cyanide 
(LD 50 10 mg/kg) and 160,000 times more potent than 
. 1-3 
cocaine in blocking axonal conduction. Their mode 
of action, however, differs from that of the local 
anaesthetics. Although chemically distinct, Kao 4 has 
shown that the toxins possess nearly identical biolog-
ical properties. Thus, at nanomolar concentrations 
1. 
they block the early transient inflow of sodium ions 
associated with the passage of an action potential in 
nerve membrane, causing respiratory failure and complete 
5 
neuromuscular block. Even at relatively high concen-
trations the potassium current is unaffected and it is 
. 
because of this specificity of action that the toxinp 
6-8 have proved useful in the study of excitation phenomena 
and the molecular nature of sodium channels in conducting 
. 9 tissue. Their specific action has raised the possibil-
ity of using the toxins in the identification and 
characterization of membrane sodium channels. 10 Binding 
experiments 11 with radioactively labelled tetrodotoxin 
indicate a scanty distribution of sodium channels. The 
use of purer, more specifically labelled saxitoxin 
1111111 
2 . 
.. 
preparations has given more reliable estimates of the 
sodium channel density in various nonmyelinated nerve 
preparations. For example garfish, lobster and rabbit 
have sodium channel densities of 35,90 and 110/µm 2 nerve 
respectively. 12 
Both toxins have become valuable tools in neuro-
pharmacological research. Tetrodotoxin has found 
clinical application as a muscle relaxant and pain-killer 
in cases of neurogenic leprosy and terminal cancer, and 
13 
as a local anaesthetic in Japan. Saxitoxin has found 
14 
notoriety as a material held by the C.I.A., and its 
15 potential use in biological warfare has been suggested. 
Saxitoxin is a metabolite of certain types of 
dinoflagellate alga, notably Gonyaulax catenella and 
Gonyaulax tamarensis. When environmental conditions are 
favourable, these organisms reproduce rapidly and discolour 
the sea - a condition referred to as a "red-tide". Such 
phenomena are endemic to the East and West coasts of 
North America and most temperate coastal waters. Shell-
fish feeding on the dinoflagellates become toxic and .may 
h d . l . . 16 d . d 17 cause uman an anima poisoning an economic amage 
to local shellfishing industries. Saxitoxin has been 
isolated as a dietary constituent of Alaskan butter clams 
(S axidomus giganteus) and the Californian sea mussel · 
18 (My tilus californianus ), and as a metabolite of axenic 
19 
cultures of Gonyaulax catenella . Saxitoxin is a minor 
constituent of the toxins produced by Gonyaulax 
t . 20 th . . d amarens~s , e maJor components, gonyautoxins II an 
III are structurally related. The toxins were also 
3 . 
isolated from infested soft-shell clams, Mya . 20 arenar1.,a. 
Saxitoxin has also been found in a fresh water blue-
21 green alga, Aphanizonomenon flos aquae. 
Three species of xanthid crab, Zosimus aeneus~ 
Platypodia granulosa and Atergatis floridus have been 
. . . 22-25 
shown to contain saxitoxin. The exoskeleton 
possesses the largest amount of toxin and large 
individual variations in crab toxicity are common. 
These observations suggest that the toxin is of 
exogenous origin but has not been positively ascribed 
to toxin producing dinoflagellate infestations. The 
sand crab, Emerita analoga contains saxitoxin in its 
26 digestive glands and reportedly feeds on dinoflagell-
ates (Gonyaulax-spp.). 
The determination of the structure of saxitoxin 
proved to be a formidable task. Initial investigations 
led to the proposal of incorrect structures, notably 
27 28 those of Russell and Rapoport and coworkers. The 
structure of saxitoxin was established by an X-ray 
11 h . d 29 d b ·1 f' d 30 crysta ograp ic stu y an su sequent y con irme . 
also by X-ray crystallography. It is a 3,4,6-trialkyl-
2,8-diiminoperhydropurine with the structure illustrated 
in (1.1) . The molecule has a perhydropurine skeleton, 
the N-3 and C-4 positions are joined by a three carbon 
bridge containing an hydrated ketone at C-12. 
dehydrates under rigorous drying conditions, an 
Saxitoxin 
observation which reconciles the difficulties in 
obtaining an accurate molecular formula. Another notable 
feature is the side-chain at C-6 which incorporates a 
carbamoyloxy group. The structures of gonyautoxins II 
' . d k 31 and III were determined by ~akanishi an cowor ers. 
.. 
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They are lla- and llS-hydr oxysaxitoxins and are 
illustrated in (1.2) and (1.3). In 1977, Kishi 
32 
and coworkers reported the total synthesis of 
d,Z.-saxitoxin. 
Tetrodotoxin is the poison classically 
associated with Puffer fish belonging to the family 
5 . 
Tetraodontidae. 33 The toxin is most highly concentrated 
in the gonads and liver with smaller amounts in the skin 
and intestines. The concentration of toxin varies 
seasonally, being at its highest prior to and during the 
breeding season. 34 35 . Mosher and coworkers ' established 
the identity of tarichatoxin from newts of the family 
Salimandridae with tetrodotoxin. 36 Mosher and coworkers 
also isolated tetrodotoxin from the skin of male and 
female Central American frogs of the genus Ate Z.opus . 
A structurally related toxin was also obtained from one 
of the frogs, Atelopus chiriquiensis. Hashimoto and 
Noguchi 37 obtained tetrodotoxin from a goby, Gobius 
. . . 
cr1..,n1..,ger . The goby exhibited greatest toxin concen-
tration in the testes and skin but not the ovaries, .and 
in further contrast to puffer fish, showed little 
seasonal but distinct geographical variation in toxicity. 
I 19 7 8 S h k d d . 3 8 . 1 d n , c eumac , How en, Spence an Quinn iso ate 
tetrodotoxin from the posterior salivary glands of the 
blue-ringed octopus, Hapalochlaena maculosa . Impure 
preparations of this toxin were previously thought to be 
distinct from tetrodotoxin and the active component was 
. 39 40 
called maculotoxin. ' These findings constitute the 
........ 
first case in which tetrodotoxin has been found in a 
venom. In all other known cases it occurs as a toxin 
in skin, muscle, liver, gonads and/or eggs. 
The structural elucidation of tetrodotoxin was 
carried out simultaneously and independently in four 
laboratories, led by Mosher 34 working with toxin from 
the California newt and Tsuda, 41 Goto 42 and Woodward 43 
all of whom used extracts from the ovaries of puffer 
6 . 
fishes. The complete structure and absolute configur-
ation were established by X-ray analysis of the toxin 
by Woodward and Gougoutas, 44 and confirmed by X-ray 
analysis of the crystalline hydrobromide salt. 45 
Racemic tetrodotoxin was synthesized in 1972 by Kishi 
and coworkers. 46 
Tetrodotoxin is a zwitterionic polyhydroxy 
2-iminoperhydroquinazoline with the structure illustrated 
in ( 1. 4) . Several features of the molecule are worthy 
of note, namely the trans -2-iminoperhydroquinazoline 
skeleton, a side-chain substituent (-CHOH-COO) on the 
bridgehead carbon atom C-8a, the carboxyl group of which 
forms a unique hemilactal link and results in an 
adamantane-like structure. 
Studies of the structure activity-relationships of 
tetrodotoxin and saxitoxin may yield information ab6ut 
the reactive components of the sodium channel. Direct 
modification of tetrodotoxin would appear productive 
because some minor alterations result in an attenuation 
f . . 47 ,48 o activity. Tetrodotoxin derivatives of decreased 
l . 
I 
activity would be desirable clinically, but the 
cost of pure toxin and the laborious process of 
isolation make this approach unattractive. An 
alternative approach is the preparation of compounds 
bearing structural resemblances to some parts of the 
7 • 
neurotoxin. 4 Kao has suggested that the guanidinium 
moiety of tetrodotoxin may be at least in part 
responsible for its highly specific physiological 
action. This hypothesis has been tested by several 
49 50 . 
workers, ' and in an extension of these studies 
51 Armarego and Reece prepared various 2-imino- and 
2-oxo-perhydroquinazolines and a zwitterionic 
2-iminoperhydroquinazoline for biological evaluation. 
Tetrodotoxin has several unusual structural features 
none of which would appear to be individually 
responsible for the physiological activity of the 
toxin. The molecule may be described in steric 
terms as being spherical in shape with a protruding 
tongue - the guanidinium group, and it is possible 
that the toxicity of tetrodotoxin is at least in 
part due to its overall shape. The present work 
was directed toward the synthesis and biological 
evaluation of a number of 2-oxo- and 2-imino-
adamantanopyrimidines* incorporating a spherical 
non-penetrating moiety and a protruding hydrophilic 
* The term adamantane was abandoned by Chemical Abstracts 
in 1972 but will be retained in the General Introduction 
and Discussion for the sake of clarity (see also p. 9 ) . 
8 . 
"tongue". The known biological activity of adamantane 
derivatives was a further consideration in the design 
of these analogues. 
No systematic attempt has been made to study the 
structure-activity relationships of saxitoxin although 
52 53 Armarego and Reece and Wegner and Rapoport have 
investigated the preparation of 2,8-disubstituted 
perhydropurines. 54 Schantz and coworkers have 
prepared an acid hydrolysate of saxitoxin in which the 
carbamyl group at 0-17 is absent. The derivative 
retains biological activity comparable to that of 
saxitoxin. Catalytic reduction of saxitoxin affords 
nontoxic dihydrosaxitoxin55 in which the hydrated 
carbonyl function at C-12 has been replaced by a 
methylene group. From these observations it can be 
concluded that the guanidinium group at C-8 and the 
hydrated carbonyl at C-12 are indispensable for 
biological activity. The aim of this work was therefore 
to prepare saxitoxin analogues incorporating a 
2,8-diiminoperhydropurine skeleton and a three carbon 
chain between N-3 and C-4 bearing a polar group at C-12. 
It was anticipated that some of the analogues 
would be less toxic than tetrodotoxin and saxitoxin 
and thus more clinically useful compounds (e.g. as 
local anaesthetics and anticonvulsants). 
I 
..J 
PAJZ1, 2 
TETRODOTOXIN ANALOGUES 
1) Nomenclature 
The term adamantane was abandoned by Chemical 
Abstracts in 1972 and replaced by tricyclo[3.3.1.1 3 , 7 J 
decane. However, in the general literature the 
systematic nomenclature has been widely adopted and 
will be retained in the present text. In the 
Experimental Sections, however, both the von Baeyer 
and the systematic nomenclature will be used, with 
the latter in brackets. Examples of the von Baeyer 
numbering system for adamantanopyrimidines are 
illustrated in (2.1) and (2.2). The carbon atoms 
numbered 1 and 9 have been chosen as loci such that 
c-1 is a quaternary carbon and the heteroatoms have 
the lowest possible numerical assignment. In both 
cases the heavy line passing through 7 atoms comprises 
the largest ring followed by the broken line (3 atomp) 
and the dotted line (1 atom). According to these 
conventions tetrahydroadamantano[2,l- d ]pyrimidin-2(1H)-
one (2.1) (systematic) is named 3,5-diazatetracyclo 
7 11 1 6 · , [7.3.1.1. ' 0 ' Jtetradecan-4-one (von Baeyer), while 
tetrahydroadamantano[l,2-d ]pyrimidin-2(1H)-one (2.2) is 
named 2,4-diazatetracyclo[7.3.l.l. 7111 o116 Jtetradecan-
3-one. A similar numbering system has been adopted for 
i 
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11. 
fused 5-membered heterocycles. In the systematic 
nomenclature a double bond within a ring (e.g. C=N) 
takes precedence over a substituent (e.g. C=O) and 
compound (2.3) is named adamantano[2,l-c]-1H-pyrazolin-
5-one. The von Baeyer numbering system for 5-membered 
heterocycles fused to an adamantane skeleton is 
illustrated in (2.3). Carbon atoms land 8 have been 
chosen as loci and again the numbering is such that C-1 
is a quaternary carbon and the heteroatoms have the 
lowest possible numbers. Accordingly, compound (2.3) 
is named 3,4-diazatetracyclo[6.3.l.16110 .o 115 Jtridec-
4,5-en-2-one in the von Baeyer nomenclature. This 
numbering system differs from that employed by 
h k b . d k 56 f d . . d. Cara arti an cowor ers or a amantanopyr1m1 ines. 
Their numbering is illustrated in figure (2.4). Carbon 
atoms land 9 have been chosen as loci but C-1 is a 
tertiary carbon atom remote from the fused pyrimidine 
ring, consequently the heteroatoms cannot be given the 
lowest possible number. Tetrahydroadamantano[2,1-d] 
pyrimidin-2(1H)-one (2.4) has been caliea56 
. 3 11 4 9 5,7-diazatetracyclo[7.3.l.l. ' 0 ' ]tetradecan-6-one 
and, while this name is unambiguous it is not strictly 
correct. 
Intermediates used in the preparation of adamantano-
pyrimidines in which the adamantane system is the only 
cyclic unit are named as substituted adamantanes because 
the von Baeyer name (tricyclo[3.3.l.l. 317 Jdecane) 
cumbersome. 
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2) Introduction 
Tetrodotoxin (1.4) has been described in steric 
terms as being spherical in shape with a protruding 
'tongue' - the guanidinium group. In order to test 
the hypothesis that the shape of the tetrodotoxin 
molecule is partly responsible for its biological 
activity it was necessary to synthesize and evaluate 
the biological properties of adamantanopyrimidines 
which incorporate a 'spherical' hydrocarbon part and 
an hydrophilic portion - the guanidinium moiety. The 
true analogues of tetrodotoxin are of the type (2.2) 
but their isomers, which are also of interest because 
their general shape is similar need to be studied. 
If the hypothesis is correct the imino compounds 
should possess an activity and mode of action similar 
to that of tetrodotoxin though of lower intensity. 
13. 
The corresponding oxo-compounds (2.1) and (2.2) which 
lack the guanidinium function but retain the general 
shape and polar nature may possess different biological 
properties if they are active. The synthesis and 
chemical properties of the imino- and oxo-adamantano-
pyrimidines are described in this Section. 
In order to prepare the required adamantano-
pyrimidines it was necessary first to prepare the 
appropriate 1,2-disubstituted adamantane derivatives. 
1,2-Disubstituted adamantanes are not readily accessible 
by the usual substitution procedures used in adamantane 
chemistry. The preparation of derivatives substituted 
in the 2-position is rendered difficult by the relative 
14. 
stability of radicals and carbonium ions at the 
1-position (tertiary bridgehead carbon). Non-selective 
substitution of adamantane compounds leads primarily to 
reactions at the tertiary carbon atoms. For example, 
the treatment of adamantane with bromine under reflux 
affords 1-bromoadamantane by an ionic process, and in 
excellent yield. 57 - 59 The successful preparation of 
60-62 . 
adamantan-2-one by Geluk and coworkers has provided 
a useful intermediate in the synthesis of 2-substituted 
adamantanes. However, radical and ionic substitution 
reactions of adamantan-2-one are not generally suitable 
for the preparation of 1,2-disubstituted adamantanes 
because they usually give rise to mixtures. For example, 
radical bromination of adamantan-2-one affords a mixture 
f 11 'bl b . d . 63 o a possi e mono rominate isomers. The syntheses 
of a variety of 1,2-disubstituted adamantane derivatives 
appropriate to the present study have been reported since 
1967. Successful general approaches have utilized 
. 64-68 intramolecular cyclization reactions of nitrenes, 
. 68 . 68-71 
carbenes or free radicals, the rearrangement of 
72-75 
substituted protoadamantanes, or the direct synthesis 
of the adamantane skeleton substituted in positions 1 and 
76 2 from individual fragments. Approaches to the 
synthesis of 1,2-disubstituted adamantanes involving 
nitrene insertions are described in section 5. 
1971 d k 77 . h . t In , Peters an cowor ers, int eir at empts 
to epimerize bicyclo[3.3.l]nonane-3 a ,7a-dicarboxylic 
acid (2 . 8) and its dimethyl ester found that these 
15. 
bicyclononanes underwent t acile ring closure to yield 
2-oxoadamantane-l-carboxylic acid or its methyl ester. 
The reaction occurs in acidic or alkaline media and has 
proved useful for the preparation of 1,2-disubstituted 
d d . . 78-82 a amantane erivatives. The preparation of 
starting materials for the syntheses of adamantano-
pyrimidines described in the following sections is based 
on earlier work. 77178 
3) Synthesis of 3,5-diazatetracyclo[7.3.l.l. 7111 0116 ] 
tetradecanes (adamantano[2,1-d]pyrimidines) and 
related compounds. 
i) Discussion 
Homoadamantane derivatives (e.g. (2.6)) are now 
83-86,88 
readily accessible and have proved to be convenient 
starting materials for the preparation of 3a,7a-di-
substituted-bicyclo[3.3.l]nonanes. 77178 The facile 
cyclization of bicyclo[3.3.l]nonane-3a,7a-dicarboxylic 
acid (2.8) to 2-oxoadamantane-1-carboxylic acid, methyl 
ester or acid chloride (see section 2) made this compound 
a good starting point for the synthesis of adamantano-
pyrimidines. The diacid (2.8) was prepared by a two 
stage oxidative cleavage of homoadamantanone (2.6) 77 , 73 
as illustrated in Scheme 2.1. Homoadamamtanone (2.6) 
was obtained by ring enlargement of adamantanone (2.5) 
with diazomethane according to the procedure of Black and 
Gill. 85 Diazomethane was generated in situ from 
~-methyl-~-nitroso-p-toluenesulphonamide 87 and the product 
was isolated by steam distillation. Homoadamantanone 
may also be prepared by the hydrolytic rearrangement of 
~o 
~ 
( 2 • 5) ( 2 • 6) 
C02H 
~ .~ 
~ 
~ 
( 2 • 8) 
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0 
~ 
C02H 
~ 
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8 U .. 
1-dichloromethyladamantane , or by a Demjanov-
Tiffeneau ring enlargement of 2-aminomethyl-2-hydroxy-
adamantane86 but the yields are considerably lower and 
in the latter case the synthesis requires one more step 
than that employed in this work. The ketone (2.6) 
afforded homoadamantan-4,5-dione (2.7) as a yellow 
crystalline solid on treatment with selenium dioxide in 
dioxan/water. Oxidative cleavage of the dione (2.7) 
with periodic acid in a modification of a previous 
method 78 gave bicyclo[3.3.l]nonane-3 a ,7a-dicarboxylic 
acid ( 2. 8) . The diacid has been shown 78 to exist 
predominantly as two rapidly interconverting, degenerate 
chair-boat, conformations as illustrated in (2.8). The 
conformations of such compounds permit the close approach 
of C-3 to the carbonyl carbon atom on C-7 and could be 
expected to facilitate ring closure to compounds with an 
adamantane skeleton. This has been found to be the 
case. d k 77 . h . Peters an cowor ers int eir attempts to 
epimerize the diacid (2.8) and its dimethyl ester 
discovered that ring closure to 2-oxoadamantane-1-
carboxylic acid and its methyl ester occurred quantit-
atively. They later demonstrated 78 that the diacid 
(2.8) could be converted into 2-oxoadamantane-1-carbonyl 
chloride (2.9) upon treatment with thionyl chloride. · 
'Treatment of dicarboxylic acids under dehydrating 
conditions usually yields the respective bis-acid 
chlorides or the corresponding anhydride, but the 
cyclization (2.8) ~ (2.9) is unusual in that regard. 
18. 
89 Masamune et al. have reported a similar reaction in 
which the endo-endo diester (2.10) undergoes an intra-
molecular Dieckmann condensation in the presence of 
methylsulphinyl carbanion to afford the keto-ester (2.11). 
Treatment of the diester with sodium methoxide resulted 
in epimerization to the exo-exo isomer presumably via 
the keto ester (2.11). Generally the Dieckmann reaction 
fails when the product cannot form a stable 6-keto ester 
enolate. Exceptions to this general rule are cases such 
as the diester (2.10) and compounds of the type (2.12) in 
which cyclization is sterically favourable. The flexib-
ility of the chair-boat conformation of the bicyclononane 
(2.12) enables the close approach of C-3 to the carbonyl 
carbon on C-7. The proximity of reactive centres pre-
disposes these compounds to intramolecular cyclization 
reactions under acidic or basic conditions which probably 
involve the movement of electrons as depicted in (2.12). 
The species x- represents a nucleophile (Cl-, Meo- etc.) 
responsible for the removal of a proton or the generation 
. 
of a partial negative charge at C-3, and R may be OSOCl 
or Cl when the diacid is treated with thionyl chloride, 
OH when a mixture of concentrated hydrochloric acid and 
glacial acetic acid (1:3) is used or OCH 3 when the 
dimethyl ester is treated with sodium methoxide. A 
point of interest is that sodium methoxide failed to 
epimer~ze the dimethyl ester of bicyclo[3.3.l]nonane-
3a,7 a -dicarboxylic acid, but under similar conditions 
the diester (2.10) was epimerized. This observation 
may be accounted for by the fact that the adamantane 
"------"' 
(2.10) 
C02Me 
C02Me 
H 
COR 
(2.12) 
19. 
-o 
(2 . 11) 
H 
20. 
·90 
skeleton is relatively str ain free and rearrangements 
and ring closures leading to adamantane structures are 
facile. While the cyclization of the diester (2.10) 
to compound (2.11) is sterically favourable it would 
appear energetically less so compared with cyclizations 
leading to the adamantane system. The formation of 
anhydrides from diacids of the type (2.12, R=OH) is 
precluded by the strain which would be inherent in 
such compounds. 
Treatment of the diacid (2.8) with thionyl chloride 
furnished 2-oxoadamantane-l-carbonyl chloride (2.9) in 
excellent yield. The acid chloride (2.9) is the key 
intermediate in the preparation of adamantanopyrimidines 
described below and in section 4. This acid chloride 
was converted into 2-oxoadamantane-l-carboxamide (2.13) 
in 90-95% yield with ammonia and ether, which is an 
80 improvement oh the method of Tabushi and Aoyama, 
(treatment of acid chloride in dry THF with 28% aqueous 
ammonia afforded the amide in 73% yield) . Reductive 
. 
amination of the keto-amide (2.13) afforded 2-amino-
adamantane-1-carboxamide (2.14). The two isomeric 
amides (2.14a) and (2.14b) were obtained in equal 
amounts, they are enantiomeric and form a racemic mixture. 
This is to be expected in view. of the symmetry of the 
starting material. In some preparations a neutral 
compound was isolated from the reaction product and was 
shown to be 2,2-dichloroadamantane by comparison with an 
91 
authentic sample. The diacid (2.8) was usually 
purified as its potassium salt, neutral impurities 
SCHEME 2.2 
0 
CONH2 
H 
(2.13) (2.14a) 
~ 
+ 
NH CONH 2 
2 
NH2 
(2.14b) 
CONH2 
N 
t-' 
. 
22. 
being extracted from a queous solution with chloroform. 
Failure to execute this purification step leads to the 
retention of adamantanone (2.5) in the diacid (2.8) 
which with thionyl chloride provides a mixture of 
2,2-dichloroadamantane and 2-oxoadamantane-1-carbonyl 
chloride (2.9). The dichloro compound survives 
subsequent reactions and is removed from acidic 
solutions of the amino-amide (2.14) by solvent extraction. 
While reductive amination of the oxo-amide (2.13) 
was found to be the most convenient route for the 
preparation of the amino-amide (2.14) a number of 
alternatives were investigated~ It was planned to 
prepare oximes or hydrazones of the keto-amide (2.13) 
which could be reduced and cleaved to afford the amino-
amide (2.14). When 2-oxoadamantane-1-carboxamide (2.13) 
was treated with hydroxylamine, hydrazine or ethyl 
92 
carbazate,_ the cyclic products adamantano[2,l-c] 
isoxazolin-5-one (2.15), adamantano[2,l-c]-1H-pyrazolin-
5-one (2.16) and 2-(N-ethoxycarbonyl)adamantano[2,1-c] 
pyrazolin-5-one (2.17) respectively.were formed. The 
intermediate acyclic oxime and hydrazones could not be 
isolated. . 93 However, 0-benzylhydroxylamine and phenyl-
hydrazine converted the oxo-amide (2.13) into 
2-(benzyloximino)adamantane-l-carboxamide (2.19) and 
2-(phenylhydrazono)adamantane-l-carboxamide (2.18). 
Chakrabarti et ai 68 have prepared similar derivatives 
of 2-oxoadamantane-l-acetamide (2.20) 
and found that while hydrazine, methylhydrazine, 
N"' NH 
c/ 
II 
0 
(2.16) 
(2.15) 
N·NHPh 
(2 .1 8) 
23. 
(2.17) 
(2 . 19) 
(2.20) 
(2.21) R=H 
(2.22) R=CH 3 
(2.23) R=CH 2 CH 20H 
(2.24) R= p -chlorophenyl 
(2.27) R=phenyl 
(2.28) R= p - nitrophenyl 
(2 . 25) R=phenyl 
(2 . 26) R= p -nitrophenyl 
0 
N 
"NR 
. 
N·NHR 
24. 
0 
4 
2 5. 
2-hydroxyethylhydrazine, a nd p-chlorophenylhydrazine 
afforded the respective cyclic products (pyridazinones) 
(2.21), (2.22), (2.23) and (2.24), phenylhydrazine and 
p-nitrophenylhydrazine yield the respective hydrazones 
(2.25) and (2.26) which cyclize to the pyridazinones 
(2.27) and (2.28) on heating at 200°c. These observ-
ations indicate that the acyclic hydrazone is formed 
first and subsequently cyclizes with elimination of 
ammonia. Chakrabarti et al . 68 were able to reduce the 
pyridazinones (2.21), (2.22), and (2.27) to deoxopyrid-
azines with an excess of lithium aluminium hydride. 
Suitable methods for the preparation of the 
amino-amide (2.14) from (2.15), (2.16), (2.18) or (2.19) 
were not forthcoming because preliminary investigations 
indicated that ring cleavage did not occur readily. 
82 In 1977, Stetter and coworkers prepared 
adamantano[2,1-c]-1H-pyrazolin-5-one (2.16) by the 
reaction of 2-oxoadamantane-1-carboxylic acid methyl 
ester (from the acid chloride and methano1 78182 ) with 
hydrazine hydrate. They found that the pyrazolinon~ 
(2.16) could be converted into 2-aminoadamantane-1-
carboxamide (2.14) in 82% yield with Raney nickel at 
100° in an autoclave. Synthesis of the amino-amide 
(2.14) by reductive amination of the oxo-amide (2.11) 
would seem to be the preferred route however because it 
is one step shorter and the overall yield from the acid 
chloride, 64% is comparable with that obtained by 
82 Stetter and coworkers. 
111 
2-Aminoadamantane-l- c arboxamide (2.14) was 
converted into l-aminomethyladamantane-2-ylamine (2.29) 
by reduction with lithium aluminium hydride. The 
diamine (2.29) was characterized as the dihydrochloride 
salt because the free base readily absorbs carbon 
dioxide from the atmosphere. It was identical with 
the diamine obtained by Chakrabarti et al. 68 from the 
reductive amination of 2-oxo adamantane-1-methylamine, 
which was prepared by a Hoffmann rearrangement of the 
acetamide (2.20). 
26. 
2-Aminotetrahydroadamantano[2,l-d]pyrimidine (2.30) 
sulphate and hydrochloride were prepared in good yields 
from the diamine (2.29) with §-methyl-iso-thiouronium 
sulphate and guanidine hydrochloride respectively. The 
hydrochloride salt was extremely hygroscopic, both the 
hydrochloride and the sulphate were characterized as 
identical picrates. Chakrabarti and coworkers 68 have 
prepared tetrahydroadamantano[2,l-d]pyrimidin-2(1H)-one 
(2.31) by two separate methods, namely i) the treatment 
of 2-aminoadamantane-l-acetamide with sodium hypobromite 
(56% yield) and ii) the reaction of l-methylamino-
adamantane-2-ylamine (2.29) with phosgene in toluene and 
pyridine (4% yield). In our hands the pyrimidinone 
(2.31) could be prepared in higher yields (93%) from · 
the diamine (2.29) in a 2-phase system (2N.NaOH/phosgene 
in toluene). 
Under the same conditions 2-aminoadamantane-l-
carboxamide (2.14) was converted into dihydroadamantano 
[2,l-d]pyrimidin-2,4(1H,3H)-dione (2.33). 
4 
(2.29) 
(2.31) 
(2.33) 
H NYO 
NH 
0 
2 7. 
(2.30) 
(2. 32) 
N~ 
NH 
0 
(2.34) 
di 
' . 
28. 
Hexahydroadamantano[2,l-dJpyrimidine (2.32) was 
prepared from the diamine (2.29) and 37% aqueous 
formaldehyde, the yield was low (10%) but may be improved 
by a different work up. The amino-amide (2.14) in 
refluxing ethyl orthoformate afforded dihyd r oadamantano 
[2,1-d ]pyrimidin-4(3 H)-one (2.34) in high yield. 
ii) P.m.r. spectra 
The p.m . r. spectra of adamantane and its 1- and 
2-monosubstituted derivatives have been previously 
. 94 95 discussed. ' The interpretation of the spectra of 
substituted adamantane compounds is facilitated by the 
absence of strong coupling and the relatively large 
chemical shift differences. Consequently, p.m.r. 
spectroscopy is the preferred method for the determin-
ation of the substitution patterns of adamantane 
compounds. The differences in the spectra of 1- and 
2-monosubstituted adamantane compounds are usually large 
enough to allow compounds of the two types to be 
distinguished. The p.m.r. spectra of 1,2-disubstituted 
and 1,2,2-trisubstituted adamantanes are usually more 
complex due to the effects of additional substituents 
and to the asymmetry of the molecules. 
The p.m.r. spectrum of adamantane in deuterio-
chloroform shows a poorly resolved doublet (J 1.7 Hz) at 
about o 1.78, with a shoulder at low field due to the 
four bridgehead protons. In the spectra of 1-substituted 
adamantanes however, resonances due to the S, y , and o 
protons are usually well separated, with the bridgehead 
(y) protons app~aring as a broad band (Wh/ 2 10 Hz) at 
4 
lower field than the oth r r protons. The spectra of 
l-adamantan-1--yloxycarbonyl chloride (Fig. 2 .1) and 1-
adamantanylcyanamide (Fig. 2.2) are representative of 
1-substituted adamantanes. In general, the chemical 
2 9. 
shifts of the o protons which are furthest from the 
substituent are displaced least from the chemical shift 
of the methylene protons of unsubstituted adamantane 
( o 1. 7 8) ( see Fig. 2. 1) . The bridgehead ( y) protons 
are displaced furthest from o 1.78 (see Fig. 2.2) but 
the magnitude of the displacement is dependent upon the 
nature of the substituent. The p.m.r. spectrum of the 
1-adamantyl cation96197 shows considerable deshielding 
of the bridgehead protons. This deshielding effect has 
been attributed to overlap of the vacant orbital lobe 
at the positively charged site with the inward project-
ing lobes of the bridgehead CH bonds. The electron 
deficiency at the 1-position is therefore shared among 
the other bridgehead positions, stabilizing the 
carbonium ion and deshielding the bridgehead protons. 
A similar mechanism may be operative in the deshielding 
. 
of bridgehead protons in 1-substituted adamantanes.' 
Substituent effects may be conveyed to the bridgehead 
protons by overlap of the inward projecting lobes of 
3 3 the sp orbitals of bridgehead CH bonds with the sp 
orbital of the carbon-substituent bond. 
The C-2 proton is a distinguishing feature of 
the p.m.r. spectra of 2-monosubstituted adamantanes. 
Similarly, the bridgehead protons adjacent to the 
2-position in adamantan-2-one and some of its derivat-
ives are clearly discernible. The p.m.r. spectrum of 
d 
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32. 
adamantan-2-ol (Fig. 2.3) e xhibits a band envelope 
between o 1.32 and 2.32 c o rresponding to 15 protons, 
whereas the proton at C-2, geminal to the hydroxy group 
appears at o 3.83 and is thus easily assigned. The 
bridgehead protons adjacent to C-2 in adamantan-2-one lie 
in the plane of the carbonyl group, and are consequently 
deshielded. They appear as a broad band (Wh/2 8 Hz) at 
o 2.41, while the remaining protons form a band envelope 
at about o 2.00 (see Fig. 2.4). 2-(~-ethoxycarbonyl)-
hydrazonoadamantane exhibits a similar effect in its 
p.m.r. spectrum (see Fig.2.5) but the bridgehead proton 
(H-1) syn with respect to the ethoxycarbonyl group is 
deshielded to a higher degree and resonates at lower 
field than the proton (H-3) anti to the substituent. 
The p.m. r. spectra of 2-oxoadamantane-1-carboxamide 
and 2-aminoadamantane-1-carboxamide are typical of 
1,2-disubstituted adamantanes. In the spectrum of the 
oxo-amide (Fi~.2.6) the single bridgehead proton (H-3) 
adjacent to the carbonyl group at C-2 appears at o 2.67, 
while the remaining adamantane protons appear as a broad 
band envelope between o 1.62 and 2.53. The amide 
protons appear as two broad and separate resonances, 
each corresponding to one proton, whereas the amide 
protons of adamantane-1-carboxamide appear as a single 
broad band. The appearance of separate signals for the 
amide protons of the oxo-amide is probably due to 
hydrogen bonding between the amide protons and · the 2-ox o 
group. 2-Aminoadamantane-1-carboxamide has a similar 
spectrum in that the amide protons give two broad and 
partially resolved signals (see Fig.2.7). The proton 
d 
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(H-2) ,geminal to the NH 2 group appears as a broad 
singlet at o 2.47, while the remaining pr otons form 
an unresolved multiplet between o 1.53 and 2.13. 
JU. 
The p.m.r. spectrum of dihydroadamantano[2,1-d] 
pyrimidin-2,4(1H,3H)-dione (Fig. 2.8) exhibits a doublet 
(J 2 3 3 Hz) for the proton at C-2, while the bulk of the 
' 
adamantane protons form a broad band envelope between 
o 1.30 and 2.47. From a vicinal coupling constant of 
3 Hz, a dihedral angle (between the C-H bonds at C-2 and 
C-3) of approximately 68° could be predicted. 98 However, 
the degree of influence of the nitrogen atom at C-2 on 
the vicinal coupling constant is unknown and it cannot 
therefore be used as an accurate measure of bond angle 
distortions at C-2. 2-Arninotetrahydroadamantano[2,1-d] 
pyrimidine also shows a doublet (J 213 3 Hz) for the C-2 
proton in its p . m.r. spectrum (see Fig. 2.9), while the 
methylene protons of the pyrimidine ring appear as a 
singlet at o 2.77. The p.m.r. spectrum of hexahydro-
adamantano[2,1-d]pyrimidine (Fig. 2.10) is more complex, 
·having broad signals for the proton at C-2 and the 
methylene group fused to C-1 of the adamantane skeleton. 
The methylene protons between the nitrogen atoms of the 
pyrimidine ring appear as a broadened doublet of 
doublets (J m g e 12 Hz) at o 4.31 and 4.67. 
From a diagnostic point of view the protons at C-2 
and adjacent to C-2 are the most useful in determining 
the substitution patterns of adamantane derivatives. 
The spectra of other 1,2-di and some 1,2,2-trisubstituted 
adamantanes will be discussed in sections 4 and 5. 
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iii) Experimental 
Microanalyses were determined by the Australian 
National University Analytical Service Unit. P.m.r. 
spectra were measured on a Varian T60~ instrument 
(chemical shifts in 8, and J values in Hz) with 
tetramethylsilane as internal standard unless other-
wise indicated. I.r. spectra (KBr discs for solids) 
were measured on a Unicam SPlOOO or a Unicam SP1050 
spectrophotometer and u.v. spectra on a Unicam SP800 
spectrophotometer. Mass spectra* were obtained on 
an AEI MS9 mass spectrometer and peak intensities 
are expressed as a percentage of the base peak. 
Melting points in °c were measured in 'Pyrex' glass 
capillaries in an Electrothermal melting point 
apparatus, and are uncorrected. The melting points 
of volatile solids were measured in 8mm. sealed tubes 
and are designated as m.p. All evaporations of 
dried solvents (Na 2so 4 , MgS0 4 ) were carried out at 
0 <35 and 20 mmHg. 
The names of new compounds are underlined at 
their first mention in the experimental section. 
Names of compounds occurring in paragraph headings 
are also underlined but this does not necessarily 
imply that the compounds are new. 
* By Dr J.K.MacLeod and his staff. 
I 
Tricyclo[3.3.1.1 317 ]decan-2-one (adamantanone) (2.5) 
Adamantanone was prepared by sulphuric acid 
oxidation of adamantane and the reaction followed by 
43. 
1 d . h h d f G 1 k d · 62 g .. c., accor ing tote met o o e u an Keizer. 
(45-58%), m.p.* 282.5-284° (lit. 61 m.p. 278-282°). 
Tricyclo[4.3.l.13 ' 8 ]undecan-4-one (homoadamantan-
4-one) (2.6) 
This compound was prepared according to the 
method of Black and Gill. 85 (85-93%), m.p.* 256-257° 
(lit. 85 m.p. 270.5-271°; lit. 86 m.p. 258-260°). 
Tricyclo[4.3.l.1 3 ' 8 Jundecan-4,5-dione (homoadamantan-
4,5-dione) (2. 7) 
Selenium dioxide oxidation of the ketone (2.6) as 
previously described 86178 afforded the dione (82%), 
0 . 86 0 
m.p. 286 (lit. m.p. 287 ) . 
Bicyclo[3.3.l]nonane-3a,7a-dicarboxylic acid (2.8) 
. 86 78 Homoadamantan-4,5-dione ' (4.45 g, 25 mmol) 
was heated in dioxane/water (3:1, 25 ml) with periodic 
acid (dihydrate, 6.84 g, 30 mmol) at 70° for 72 h. 
Most of the solvent was evaporated and the residue in 
ether (200 ml) was washed with lN sulphuric acid 
saturated with sulphur dioxide until the organic layer 
was colourless, and then extracted with 2N potassium 
hydroxide (3x35 ml). The alkaline extracts were 
washed with hexane and then acidified with lON 
r 
I 
I 
I 
I 
44. 
hydrochloric acid (cool i ng). The white crystalline 
solid that separated was extracted into ethyl acetate 
(4x35 ml). The diacid (4.69 g, 87%), m.p. 180-181.5°, 
was obtained by evaporation of the washed and dried 
extracts (lit. 78 m.p. 180.5-181°) v 1690 (s, C=O), 
max 
1410, 1265, 1230. 
2-0xotricyclo[3.3.l.1 3 ' 7 Jdecane-l-carbonylchloride 
( 2-oxoadamantane-1-carbonylchloride) ( 2. 9) 
The diacid (2.8) was treated with thionylchloride 
by the method of Peters et az. 78 to afford the acid 
chloride (2.9) (95-98%), m.p. 84-86°. 
(acid chloride C=O), 1716 (ketone). 
V 1795 
max 
2-0xotricyclo[3.3.l.13 ' 7 Jdecane-l-carboxamide 
(2-oxoadamantane-1-carboxamide) (2.13) 
Ammonia gas was bubbled through an ice cold 
solution of 2-oxoadamantane-1-carbonylchloride (9.5 g, 
44.8 rnrnol) in dry ether (290 mls) for 1 h. The 
mixture was evaporated and the residue partitioned· 
between chloroform (100 ml) and water (75 ml). The 
aqueous phase was extracted with chloroform (3x50 ml) 
and the combined extracts were washed ·with 10% aqueous 
sodium carbonate (SO ml) and water (50 ml), and dried. 
Evaporation of the extracts afforded the oxo-amide 
(2.13) (8.5 g, 98%) which, when recrystallized from 
0 . 80 0 toluene had m. p. 170-171.5 (lit. m.p. 177-177.5). 
v 3440, 3360, 3305, 3210 (NH str), 1720 (C=O), 1675, 
max 
1624 (amide) .. P.m.r. cS(CDC1 3 ) 1.62-2.53 (m, 12H), 
4 1' J • 
.. 
2.67 (m, lH, H-3) ,5.38- 6.62 and 6.93-8.12 (very 
broad, each corresponding to lH, NH 2 ). 
2-Aminotricyclo[3.3.l.1 317 Jdecane-l-carboxamide 
(2-aminoadamantane-1-carboxamide) (2.14) 
2-0xoadamantane-1-carboxamide (2 .13) (3. 86 g, 
20 mmol) was dissolved in ethanol (175 ml) and gaseous 
ammonia bubbled in for 30 min at 25° and at s 0 for 30 
min. 10 % Palladium-on-charcoal (1.93 g) was added 
0 
and the mixture shaken with hydrogen at 20 and 4 atm 
for 48 h. The catalyst was removed and the solvent 
evaporated. The residue was dissolved in chloroform 
and extracted into 4N hydrochloric acid. The aqueous 
solution was basified and extracted with chloroform 
(5x50 ml). Evaporation of the dried extracts gave 
2-aminoadamantane-1-carboxamide (2.5 g, 65%) m.p. 
0 . 82 0 140.5-142 (toluene) (lit. m.p. 135 ) . v 3400 
max 
( NH st r ) , 16 5 5 , 16 1 0 ( amide ) . P. m. r. c5 ( CDC 1 3 ) 
1 . 5 0 ( s , NH 2 ) , 1 . 5 3- 2 . 13 ( m, 13 H) , 3 . 0 3 ( s , lH 
vicinal to N~ 2 ), 5.80-7.60 (v.br, 2H,· CON!:! 2 ). 
Evaporation of the first chloroform extract 
occasionally gave small amounts of a neutral product 
which was shown to be dichloroadamantane by comparison 
90 0 
with an authentic sample. M.p. 201.5-203.5 
(lit. 90 m.p. 203-204°) (Found: C, 58. 3; H, 6. 7; 
Cl, 34.0. 
Cl, 3 4. 6) . 
Cale. for c 10H14cl 2 : C, 58.6; H, 6.9; 
v 2970, 2940, 2880, 1455, 1358, 960, 
max 
907, 810, 795, 650. P.m.r. (CDC1 3 ) 1.53-2.1 (m, 8H), 
2 . 15 - 2 . 7 ( m , 6 H ) ; m/ e 2 0 8 ( 0 . 6 % ) , 2 0 6 ( 2 . 7 ) , 2 0 4 ( 3 . 4 ) 
4 . 
6 10 1 5 .. 3-0xa-4-azatetracyclo[6. 3 .l.l ' .0 ' ]tridec-4,5-
en-2-one (adamantano [2, 1-c] isoxazolin-5-one) (2 .15) 
A solution of the oxo-amide (2.13) (96 mg, 0.5 mmol) 
and hydroxylamine hydrochloride (139 mg, 2 mmol) in 95 % 
ethanol containing potassium hydroxide (112 mg, 2 mmol) 
was heated under reflux for 20 min. The cooled 
solution was extracted with chloroform and the extracts 
were combined and washed with water. Evaporation of 
the dried extracts gave the isoxazolin-5-one (60 mg, 
6 3 % ) • It had m.p. 179-181° after sublimation at 
70°/0.4 mm (Found: C, 6 9. 5; H, 6 . 7 ; N, 7. 1. 
CllH13N02 requires C, 69.1; H, 6. 9; N, 7 . 3 % ) . 
\) 1790 ( C=O) , 1630 ( C=N) . 
max 
3,4-Diazatetracyclo[6.3.l.16 ' 10 .o115 ]tridec-4,5-
en-2-one (adamantano [2, 1- c ] -lH-pyrazolin-5-one) (2 .16) 
The oxo-amide (2.13) (96 mg, 0.5 mmol) was heated 
under reflux with hydrazine hydrate (10 ml) for 45 min. 
The solution was evaporated to dryness and the residue 
. 
recrystallized from 95% ethanol to afford the p yra~olin-
5-one (91 mg, 96%). M.p. 223-225° (lit. 82 m.p. 220°) 
(Found: C, 69.5; H, 7.3; N, 14.9. Cale. for 
v 3140 
ma x 
(br, NH str), 1690, 1660 (amide), 1630 (C=N). 
6 10 · 1 5 .. 3,4-Diazatetracyclo[6.3. l .l ' .0' ]tridec -4,5-
en-2-on-3-ethyl carboxylate (adamantano-[2,l- c] -
pyrazolin-5-on-3-ethyl carboxylate) (2.17) 
2-0xoadamantane-1-carboxamide (386 mg, 2 mmol) 
in ethanol (2.5 mls) was treated with ethyl carbazate 
(208 mg, 2 mmol) and the mixture heated under reflux 
for 3 h. The solution was cooled in ice and the 
crystalline pyrazolin-5-one was collected (438 mg, 
83.6%). It had m.p. 126-127° after recrystallization 
from ethanol (Found: C, 63.1; H, 6.9; N, 10.6. 
N, 10.5%). v 1799 (ester C=O), 1765 and 1754 
max 
47. 
(amide C=O), 1647 (C=N). P.m.r. o (CDC1 3 ) 1.42 (t, 3H, 
CH 2C!i 3 ), 1.60-2.50 (m, 12H), 3.05 (m, lH, H-3), 
4.46 (q, 2H, C~ 2cH 3). 
2-(Phenylhydrazono)tricyclo[3.3.l.13 ' 7 ]decane-l-
carboxamide (2-(phenylhydrazono)adamantane-1-
carboxamide) (2.18) 
The oxo-amide (2.13) (96 mg, 0.5 mmol) in methanol 
(1 ml) was treated with phenylhydrazine (0.02 ml, 
2 mmol) and the solution shaken until crystallization 
was complete. The colourless solid was collected, 
washed with cold methanol (5 ml) and dried in a vacuum 
to yield the phenylhydrazone (80 mg, 57%), m.p. 
190-200° (dee.) (Found: C, 69.7; H, 7.6; N, 14.4. 
48. 
v 3 3 8 0 , 3 2 0 0 ( NH st r ) , 16 7 5 ( amide ) , 1 6 1 0 ( C = N ) . 
max 
P . m . r . o ( C 2 ~o 5 OD ) 1 . 3 - 2 . 0 ( m , 12 H ) , 2 . 2 5 ( m , 1 H , H - 3 ) , 
6.1-7.0 (m, SH, aromatic protons). 
2-(Benzyloximino)tricyclo[3.3.l.1 317 Jdecane-l-
carboxamide (2-(benzyloximino)adamantane-1-carboxamide) 
(2.19) 
To a solution of Q-benzylhydroxylamine 93 (86 mg, 
0.7 mmol) in methanol (2.5 ml) was added the oxo-amide 
(2.13) (96 mg, 0.5 mmol) and the mixture boiled under 
reflux for 2 h. The solution was evaporated, dried 
in a vacuum, and the residue recrystallized from 
0 petroleum ether, b.p. 40-60 . The crystalline 
benzyloxime (108 mg, 73%) had m.p. 118-121° (Found: 
C, 73.1; H, 7.6; N, 9.2. 
C, 72.4; H, 7.4; N, 9.4%). 
c 17 H22 N2o2 requires 
v 3410 (NH str), 
max 
1670 (C=O). P.m.r. o(CDC13) 1.5-2.4 (m, 13H), 5.13 
(s, 2H, OCH 2 ), 7.37 (d, SH, aromatic protons). 
2-Aminotricyclo[3.3.l.1 3 ' 7 Jdecane-l-~ethylamine 
I 
( l-aminomethyladamantan-2-ylamine) ( 2. 2 9) 
2-Aminoadamantane-1-carboxamide (500 mg,2.6 mmol) 
in glyme (15 ml) was treated with lithium aluminium 
0 hydride (5.2 mmol) and the mixture heated at 80 for 
3 days. To the cooled solution was added saturated 
aqueous sodium carbonate and the mixture boiled for 
10 min. The solution was then extracted with 
chloroform. The extracts were dried (Na 2so 4), 
filtered, and the filtrate evaporated to afford the 
I 
I ' 
49. 
diamine as a white solid ( 356 mg, .77%), m.p . .. 129-131°. 
0 68 . The dihydrochloride had m.p. 314 (dee.) (lit. m.p. 
0 300-310 (dee.)) . \) 3400 (br, NH str), 1585, 
max 
14 7 0 , 13 8 5 , 13 2 5 : m/ e 18 0 ( M , 3 3 % ) , 16 4 ( 1 0 0 ) . 
3,5-Diazatetracyclo[7.3.l.17 ' 11 .o1 ' 6 Jtetradecan-4-imine 
(2-amino-tetrahydroadamantano[2,1-d]pyrimidine)(2.30) 
sulphate, hydrochloride and picrate. 
l-Aminomethyladamantan-2-ylamine (2.29) (90 mg, 0.5 
mmol) in water (1 ml) was treated with §-methyl-i so -
thiouronium sulphate (69 mg, 0.25 mmol) and the mixture 
heated under reflux for 1 h. The solution was evaporated 
to dryness and the residue recrystallized from water to 
yield the sulphate (125 mg, 98%), m.p. 355-357° (dee.) 
(Found: 
N, 16.5; 
N, 16.3; 
S, 6.3%). 
S, 6.0. 
\) 
max 
c24 H40 N6o4s requires 
3260 (NH str), 1680, 1630 
(cyclic guanidino). P.m.r. (D 20) 1.2-2.2 (m, 13H), 2.77 
(s, 2H, 
NH) : m/e 
CH 2 of heterocyclic ring), 3.28 (m, lH vicinal to 
+ 205 (100) (c12 H19N3 ) . The picrate had m.p. 
230-232° after recrystallization from ~thanol (Found: 
C, 49.8; H, 5.1; N, 19.4%). \) 3440, 3323, 3200, 
max 
1680, 1660, 1640, 1625, 1582, 1376, 1345, 1324, 1275. 
The diamine (2.29) (180 mg, 1 mmol) in water (1 ml) 
was treated with guanidine hydrochloride (95 mg, 1 mmol) 
and the mixture heated on a steam bath for 1.5 h. 
Evaporation of the solution afforded the hydrochloride 
as an hygroscopic glass (209 mg, 86.7%), \) 3400, 3170 
max 
(NH str), 1670, the picrate of which had an infrared 
spectrum identical with that described above. 
•I 
I 
5 0. 
. 7, 11 . 1, G .. 3, S-D1azatetracyclo [7. 3 . 1.1 , . o· J t e tr a d ecan-4-one 
(tetrahydroadamantano[2,1- d ]pyrimidin-2(1H)-on~ (2.31) 
l-Aminomethyladamantan-2-ylamine (2.29) (900 mg, 
5 mrnol) was suspended in ice cold water (5 ml) and the 
vigorously stirred mixture treated with 20 % phosgene 
in toluene (4.9 ml, 24 mrnol) and 2N sodium hydroxide 
(8.4 ml, 48 mrnol) simultaneously (over 20 min), 
ensuring that the solution remained alkaline. The 
solution was stirred at 20° for 18 h. The treatment 
was repeated and stirring continued for 12 h. The 
mixture was partitioned between chloroform and lN 
hydrochloric acid. The aqueous layer was extracted 
with chloroform (3x50 ml) and the dried extracts 
afforded, on evaporation, the pyrimidin-2-one (2.31) 
( 9 5 6 mg , 9 3 % ) • 0 It had m.p. 324-328 (dee.) after 
recrystallization from dimethylformamide (lit. 68 m.p. 
310-320° (dee.); 4% yield from phosgene and pyridine) 
(Found: C, 70.0; H, 8.6; N, 13.7. Cale. for 
~12H17N20: C, 69.9; H, 8.8; 
(NH str), 2260, 1685 (C=O). 
N, 13.6 %) v 3250 
max 
P.m.r. cS (CDC1 3 ) 1. 76-2. 30 
(m, 13H), 2.42 (m, lH vicinal to NH), 2.63 
(m, Wh/ 2 14, 2H, CH 2 of heterocyclic ring). 
. 7 11 1 6 3,5-D1azatetracyclo[7.3.l.l ' .O ' ]tetrade c a n e 
dipicrate (hexahydroadamantano[2,1- d ]pyrimidine) (2.3 2 ) 
l-Aminomethyladamantan-2-ylamine (180 mg, 1 mmol) 
was dissolved in 37 % aqueous formaldehyde and set aside 
for 18 h. The solution was evaporated and the r esidue 
dissolved in saturated ethanolic picric acid. Wate r 
was added until turbidity persisted and the mixture 
cooled. The dipicrate (66 mg, 10%) was 
recrystallized from aqueous ethanol and had m.p. 
0 180.5-183 (Found: C, 44.4; H, 3.9; N, 17.1. 
c24 H26 N8o14 requires C, 44.3; H, 4.0; N, 17.2%). 
\) 3150 (NH str), 1635, 1610, 1575, 1540. P.m.r. 
max 
51. 
+ 1. 32-2. 25 (m, 13H) , 2. 88 (m, 2H, C!:! 2NH 2 ) , 
+ 3.50 (m, lH vicinal to N!:! 2 ) , 4.67, 4.31 (dd, 2H, 
+ + + J 12 , NH 2 CH 2 NH 2 ) , 7 . 3 2 ( m , 4 H , 2 NH 2 . ) , 8 . 7 2 
(s, 4H, aromatic protons). 
. 7 11 1 6 3,5-Diazatetracyclo[7.3.l.l ' .0' ]tetradecan-
2,4-dione(dihydroadamantano[2,l-d]pyrimidin-2,4 
(lH, 3tl)-dione) (2.33) 
2-Arninoadamantane-1-carboxamide (2.14) (388 mg, 
2 rnrnol) was treated with phosgene in toluene and 
2N sodium hydroxide as for the preparation of the 
pyrimidin-2(1!:!)-one (2.31) and gave the dione 
(299 mg, 68%); m.p. 290° after recr~stallization 
from chloroform (Found: C, 63.7; H, 7.4; N, 12.4. 
N, 12.0%). \) 3340 (NH str), 1715 (s, C=O). 
max 
P.m.r.o((CD 3 ) 2 SO) 1.30-2.47 (m, 13H), 3.48 (d, J .3, lH 
vicinal to NH), 7.80 (m, lH, NHCO), 10.03 (m, lH, 
CONHCO) . 
r: 2 :J • 
3 , S - Di a z cl t c tr cl c y c 1 o l 7 . 3 . .l . 1 7 ' 11 . O 1 ' 6 ] t c tr c1 d c ·c - 4 , 5 - c n - 2-0110 
(dihydroadamantano[2,1- d ]pyrimidin-4(3~)-one) (2.34) 
A solution of the amino amide (2.14) (100 mg, 0.52 
rnrnol) in ethyl orthoformate (4 ml) was boiled under 
0 
reflux for 2 h. and then kept at 20 for 12 h. The white 
solid was collected and recrystallized from ethyl ortho-
formate to yield the pyrimidinone (71 . 5 mg, 68%) m.p. 
176-178 o ( d) (Found: C, 6 0 . 9; H, 8 . 6 ; N, 11. 7 . 
4) . 7 11 1 6 Synthesis of 2,4-diazatetracyclo[7.3.l.l. ' O' J 
tetradecanes (adamantano[l,2-d]pyrimidines) and 
related compounds 
i) Discussion 
In order to prepare the second of the proposed 
analogues of tetrodotoxin it was necessary to convert 
2-oxoadamantane-1-carbonyl chloride (2.9) into 
2-oxoadamantan-1-ylamine (2.37), to perform a 
one- carbon homologation of the ketone at C-2, and 
finally, to cyclize the derived diamine. 
2-0xoadamantane-1-carbonyl azide (2.35) was 
prepared in high yield by treatment of the carbonyl 
chloride (2 . 9) with sodium azide at low temperature. 
Thermal rearrangement of the carbonyl azide (2.35) 
with elimination of nitrogen in dry benzene afforded 
2-oxoadamantan-1-ylisocyanate (2.36) which, on hydroylsis 
0 0 
~ 
. COCl /~/ 'CON3 
(2.9) (2.35) 
0 0 
N·C·N 
H II H 
0 
(2.38) 
SCHEME 2.3 
~ 
(2.36) 
(2.37) 
0 
NCO 
0 
NH2 
U1 
w 
. 
with dilute aqueous hyd r ochloric acid gave 
2-oxoadamantan-1-ylamine (2.37) (see Scheme 2.3). 
The amino-ketone (2.37) may be isolated as 
its hydrochloride salt by evaporation of the aqueous 
acid solution, or as the free base by basification 
of the reaction mixture followed by extraction of 
the product into chloroform. When the isocyanate 
(2.36) was heated in aqueous acetone a quantitative 
yield of the symmetrical urea (2.38) was obtained. 
Small quantities of the urea (2.38) were also 
obtained during the hydrolysis of the isocyanate 
(2.36) in dilute aqueous hydrochloric acid. The 
urea (2.38) was difficult to hydrolyse and could not 
be converted into the amino-ketone (2.37). Usually 
5 4. 
the intermediate carbonyl azide (2.35) and isocyanate 
(2.36) were isolated before proceeding with the next 
step. However, the amino-ketone (2.37) may be 
prepared without isolating the intermediates (2.35) 
and (2.36), although the overall yield is lower . 
. 
Having prepared 2-oxoadamantan-1-ylamine (2.37) 
it was then necessary to introduce a -C-N fragment at 
C-2. A variety of methods are available for the 
one-carbon homologation of adamantan-2-one and it was 
expected that some of these reactions could be us~ful 
for the homologation of the amino-ketone (2.37). 
Among the most promising are the reaction of 
adamantan-2-one (2.5) with tosylmethyl isocyanide 
(TosMIC) 99 ,lOO to yield 2-cyanoadamantane (2.39), and 
hydrocyanation of the ketone with liquid hydrogen 
55 . 
SCHEME 2.4 
H 
,' CN 
(2.39) 
(2.40) 
0 
( 2 • S) 
(2.41) 
(2.42) 
56. 
. UG . ·101 
cyanide or acetone cy ~nohydrin to afford 
adamantanone cyanohydrin (2.40). The Wi ttig103 and 
Cope l0 4 ,lOS reacti·ons of d 2 h' h ff d a amantan- -one w ic a or 
adamantan-2-ylidenes of the type (2.41) and (2.42) are 
also potentially useful (see Scheme 2.4). 
2-Cyanoadamantane (2.39) can be prepared in high 
yield by the reaction of adamantan-2-one (2.5) with 
TosMIC in the presence of a strong base. It was hoped 
that the same reaction could be applied to the prepar-
ation of 2-cyanoadamantan-l-ylamine (2.43) from 
2-oxoadamantan-l-ylamine (2.37). However, when the 
amino-ketone (2.37) in glyme was treated with TosMIC 
and potassium-t-butoxide, the dihydropyrazine (2.44) 
was formed in high yield (see Scheme 2.5). The 
dihydropyrazine (2.44) could also be prepared by 
heating the amino-ketone (2.37) in benzene with 
azeotropic distillation of water, or by heating in 
glyme with potassium-t-butoxide. However, the 
dihydropyrazine could not be converted into the 
. 
amino-ketone (2.37) by acid hydrolysis. Under the 
anhydrous conditions of the reaction with TosMIC it is 
not surprising that the amino-ketone (2.37) forms a 
Schiff's base - the dihydropyrazine (2.44). The 
amino-nitrile (2.43) was not detected in the reaction 
mixture and the failure of the reaction with TosMIC 
may be attributed to two causes. Firstly, that the 
Schiff's base formation is rapid and irreversible under 
the conditions employed, and secondly, that steric 
interference from the amino group adjacent to the ketone 
57. 
SCHEME 2.5 
0 H CN 
7 / .... . 
(2.37) (2.43) 
2 
16 19 
14 N 
N 5 
7 
11 9 
(2.44) 
H 
0 I 
7 / 
NHTs NHTs 
(2.45) (2.46) 
e g :J • 
may destabilize the bulk y intermediates formed by the 
reaction of the ketone with the TosMIC anion. These 
effects contribute to the preferential formation of 
the dihydropyrazine (2.44) in the TosMIC reaction 
rather than the desired product (2.43). Protection 
of the amino group of the amino-ketone (2.37) by 
tosylation should prevent the formation of the 
dihydropyrazine, and the tosyl derivative (2.45) was 
prepared by conventional methods. However, treatment 
of the tosyl derivative (2.45) with TosMIC and 
potassium-t-butoxide under a variety of conditions 
failed to afford the desired product (2.46), but a 
mixture of the dihydropyrazine (2.44) (17%) and starting 
mater i a 1 ( 2 . 4 5 ) ( 7 3 % ) was obtained . It is probable 
that the dihydropyrazine (2.44) was formed by the 
condensation of two molecules of the tosylamino-ketone 
(2.45) followed by cleavage of the tosyl groups. The 
formation of a stable anion under the strongly basic 
reaction conditions should prevent the cleavage of the 
. 
tosyl group in the starting material and favour the 
formation of the dihydropyrazine by intermolecular 
attack of the anion on the carbonyl group, followed by 
loss of the tosyl group. Again steric effects are 
probably responsible for the failure of the cyanation 
reaction and also for the low yield of the dihydro-
pyrazine (2.44) in this case. The use of TosMIC for 
the one-carbon homologation of the ketones (2.37) and 
(2.45) proved unsuccessful and a more suitable method 
was sought. 
59. 
58a 
Replacement of the OH group by an NHR group in cyanohydrins most 
* probably involves the following mechanism: 
* 
:::,..., 
OH 
NHR 
- CN 
+ CN 
0 
/
CN 
>'\~...-___._..,.::>=NR 
NR 
- RNH 2 
OH 
NHR 
See P. Sykes, "A Guidebook to Mechanisms 1.n Organic Chemistry", 
Longman, 1970, pp. 184-186 
86 Schlatmann and coworkers prepared 2-cyano-2-
hydroxyadamantane (2.40) in 82% yield by treating 
adamantan-2-one (2.5) with liquid hydrogen cyanide 
5 9. 
in pyridine. We were able to prepare the cyanohydrin 
(2.40) in higher yields (91%) by using excess acetone 
cyanohydrin and a catalytic amount of triethylamine 
in the cold and under a nitrogen atmosphere. The facile 
nature of the hydrocyanation and the convenient product 
work-up made it a promising reaction for the homologation 
of the amino-ketone (2.37). The amino-ketone (2.37) 
was dissolved in acetone cyanohydrin and triethylamine 
under the usual conditions, however, the only product 
was the tetrahydropyrazine ( 2. 4 8) ( see Scheme 2. 6) . 
The tetrahydropyrazine (2.48) was most probably formed 
by the addition of hydrogen cyanide to the carbon-nitrogen 
double bond of the dihydropyrazine (2.44). On the 
other hand, 2-cyano-2-hydroxyadamantane (2.40) is 
106 known to react with ammonia to yield 2-amino-2-
cyanoadamantane and the possibility that the amino group 
,er\~ c.es .. 
of the amino-ketone (2.37) reacts with the hydroxy·group 
of the cyanohydrin (2.47), followed by intramolecular 
imine formation to afford the tetrahydropyrazine (2.48) 
should also be considered. The di-HCN adduct of the 
dihydropyrazine (2.44) could not be detected in the 
product by mass spectrometry. The tetrahydropyrazine 
(2.48) could be converted into the dihydropyrazine 
(2.44) by heating in solution or at the melting point 
whereby hydrogen cyanide was liberated. Protection of 
the amino grqup of the amino-ketone (2.37) was again 
60. 
SCllEME 2.6 
0 
7 / 
(2.37) (2.47) 
r 9 
7 11 
5 N 
22 
13 
16 
N 14 
I 
19 2 H CN 
. 
(2.48) 
0 
NHTs NHTs 
(2.45) (2.49) 
necessary to prevent the formation of the dihydro-
pyrazine (2.44) and hence the tetrahydropyrazine 
(2.48). Treatment of the tosylamino-ketone (2.45) 
with acetone cyanohydrin and triethylamine under the 
usual conditions afforded the cyanohydrin (2.49) ' in 
Gl. 
high yield. The product appeared to be quite stable 
to recrystallization from ether and could be stored 
in the solid state at s0 c for long periods without 
appreciable decomposition. It is not indefinitely 
stable in solution however, and this observation will 
be discussed later with regard to the reactions of the 
cyanohydrin (2.49). 
The second analogue, isomeric with the amino-
pyrimidine (2.30) does not possess an hydroxy group 
in the pyrimidine ring and it was therefore necessary 
to remove the 2-hydroxy group from the cyanohydrin 
(2.49) to afford 2-cyanoadamantan-1-yl(~-toluene-p-
sulphonyl)amine (2.46). The removal of the hydroxy 
function at the cyanohydrin stage would also prevent 
its interference in later reactions. A number of 
methods were investigated for the removal of the 
2-hydroxy group from the cyanohydrin (2.49). The 
treatment of the cyanohydrin (2.49) with thionyl 
chloride followed by zinc in acetic acid, according 
d ·11 107 ff d d to the method of Stetter an Ti manns a ore a 
mixture of products (see Scheme 2.7). The product 
from the reaction of the cyanohydrin (2.49) with 
thionyl chloride had the molecular formula 
Only traces of chlorine were detected 
· SCHEME 2.7 
OH 
' 
~CN 
~ 
NHTs 
(2.49) 
+ 
NHTs 
(2.50) (2.45) 
C19H22N2 S204 
0 
+ 
NHTs 
(2.51) 
H 
~OH 
NHTs 
°" N 
. 
G J. 
in the analysis and the product was probably a 
sulphonic acid. This compound, on treatment with 
zinc and acetic acid afforded a mixture which was 
shown by t.l.c. and p.m.r. to be composed of 
1-(~-toluene-p-sulphonyl)aminoadamantane (2.50), 
2-oxoadamantan-l-yl(~-toluene-p-sulphonyl)amine (2.45) 
and 2-hydroxyadamantan-l-yl(~-toluene-p-sulphonyl)amine 
(2 . 51) together with minor unidentified products. The 
desired compound (2.46) could not be identified in the 
mixture and the method was abandoned. Ziegler and 
WenderlOS,l0 9 have described a method for the 
conversion of aliphatic ketones into nitriles by the 
base-induced decomposition of methyl dialkylcyano-
diazenecarboxylates of the type (2.53) where Rand R1 
are alkyl groups (Scheme 2.8). The same procedure 
has been used by Mattes et az. 110 for the one-carbon 
homologation of a ketone when the use of TosMIC was 
unsuccessful. By a modification of the method of 
'r~r1~(A; 
Ziegler and Wender109 it was hoped to displac@ the 
. 
2-hydroxy group of the cyanohydrin (2.49) with ethyl 
carbazate to afford the hydrazine (2.54) as shown in 
Scheme 2.9. Oxidation of the hydrazine followed by 
base-induced decomposition of the ethyl diazene-
carboxylate should afford the cyano compound (2.46"). 
Unfortunately, ethyl carbazate failed to displace the 
2-hydroxy group of the cyanohydrin (2.49) without 
extensive decomposition of the cyanohydrin to the 
ketone, and this approach was abandoned. 
SCHEME 2.8 
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. 
~he tosylamino-ketun e (2.4 ~ ) r e ac ts wl th 
ethyl carbazate in refluxing ethanol and afford s a 
quantitative yield of 2-(~-ethoxycarbonyl)hydrazono-
adamantan-l-yl(N-toluene-p -sulphonyl)amine as a 
mixture of isomers (2 .55a) (58%) and (2 .SSb) (42%). 
GG. 
The relative proportions depend upon the reaction 
time i.e. long reaction times favour the thermodynam-
ically more stable anti isomer (2.55a) while shorter 
reaction periods result in a predominance of the 
kinetically controlled syn isomer (2.55b) (see 
section 4) ii)). Attempts to prepare the hydrazine 
(2.54) by treatment of the hydrazone (2.55) with 
acetone cyanohydrin and triethylamine under the usual 
conditions afforded only starting material. An hydrogen 
cyanide adduct could not be isolated, although some 
epimerization of the hydrazone (2.55) had occurred, 
indicating that a reversible addition had probably 
taken place. The epimerization could also have 
occurred during the aqueous work-up, and the behaviour 
of the hydrazone in the presence of deuterium oxide 
and sodium deuteroxide will be discussed later (s ee 
Se ction 4)ii)). Because of the lack of success in 
the three approaches described above it was decided 
to leave the 2-hydroxy group of the cyanohydrin (2.49) 
in place but masked by an appropriate protecting group. 
The protecting group ideally should survive reduction 
of the nitrile and be removed prior to or following 
the cyclization of the diamine. Protection of the 
2-hydroxy group by tosy l ation or mesylation was 
unsuccessful because of the instability of the 
starting material and presumably also because of 
the ease of hydrolysis of the tertiary tosyl or 
mesyl derivative. The attempted preparation of 
the pyranyl ester of the cyanohydrin (2.49) was 
also unsuccessful due to rapid decomposition of 
the starting material (i.e. loss of HCN) under the 
reaction conditions employed . Acetylation of the 
cyanohydrin (2.49) occurs readily in pyridine-acetic 
anhydride and affords a promising protected derivat-
ive (2.52). Unfortunately its low solubility, slow 
rate of catalytic reduction and ready reductive 
cleavage with lithium aluminium hydride made 
acetylation an unsuitable method for the protection 
of the 2-hydroxy group of the cyanohydrin (2.49). 
G'l. 
The presence of an hydroxy group in the proposed 
tetrodotoxin analogue would not appear to interfere 
with the initial postulate that the spherical shape 
of the tetrodotoxin molecule is partly responsible. 
for its toxicity. Indeed, the incorporation of a 
polar group in close proximity to the guanidinium 
moiety may actually enhance the ability of the analogue 
to bind to the sodium channel, and thus enhance th~ 
biological activity of the molecule. For these 
reasons , attempts to remove the hydroxy group were 
abandoned, and the reduction of the cyanohydrin and 
cyclization of the derived diamine was undertaken. 
G8 . 
Several methods are available for the . conversion 
of the cyanohydrin (2.49) into the corresponding amino-
alcohol (2.56). 86 For example, Schlatmann and coworkers 
reduced 2-hydroxy-2-cyanoadamantane (2.40) with hydrogen 
over platinum oxide in ethanol-hydrochloric acid, while 
111 112 Sasaki et al . ' prepared 2-hydroxy-2-aminomethyl 
homoadamantane by reduction of 2-hydroxy-2-cyanohomo-
adamantane with lithium aluminium hydride or by catalytic 
reduction over platinum oxide. Catalytic reduction of 
the cyanohydrin (2.49) according to the procedure of 
86 Schlatmann et al. was attempted, but afforded a mixture 
of the amino-alcohol (2.56), the alcohol (2.51) and the 
ketone (2.45). The desired product (2.56) could be 
isolated from the mixture in an overall yield of 73%. 
The reaction time (~ 4 days) was quite long, and this 
was probably a consequence of steric hindrance, or of 
catalyst poisoning by the p -toluenesulphonyl protecting 
group, hydrogen cyanide liberated in the decomposition of 
· the cyanohydrin (2.49) or by hydrochloric acid in the 
. 
reaction medium. Fresh platinum oxide was added d~ring 
the reaction to counter these effects. Apart from the 
long reaction time, the main difficulty arose from the 
instability of the cyanohydrin and the consequent 
formation of by-products. The catalytic reduction ·of the 
acetate (2.52) should proceed without the formation of 
the ketone (2.45) and the alcohol (2.51). Unfortunately, 
the reduction of the acetate (2.52) was extremely slow 
and was not pursued further. 
69. 
0 
NHTs NHTs 
(2.45) (2.52) 
NHTs NHTs 
(2.51) (2.56) 
TABLE 2.1 Products (% yield) 
Reagent Starting Amino-alcohol Alcohol Ketone 
material (2.56) (2.51) (2.45) 
Pt02/H 2 Cyanohydrin 73 13.8 7 (2.49) 
* "Vitride" Cyanohydrin 45 51 
(2.49) 
LAH Cyanohydrin 67 28 
(2.49) 
B2H6 Cyanohydrin No reaction ( 9 4 % recovery) (2.49) 
Pt02/H 2 Acetate No reaction ( 9 2 % recovery) (2.52) 
LAH Acetate 93 
(2.52) 
* 
70. 
Reduction of the cy a11ohydrin· (2.49) or its ace tate 
(2.52) by a metal hydride should be more rapid than the 
catalytic methods described previously. Provided that 
the reduction of the cyanohydrin is sufficiently fast, 
the amounts of the decomposition products (2.45) and 
(2. 51) could be significantly reduced. "Vitride" 
(NaAlH 2 (0CH 2cH 2ocH 3 ) 2 ) in benzene at room temperature 
afforded the amino-alcohol (2.56) in 45% yield, the 
remainder of the product being the alcohol (2.51). The 
same products were obtained when lithium aluminium 
hydride was used. At elevated temperatures the alcohol 
(2.51) was the major product while at room temperature 
the amino-alcohol (2.56) predominated (67%). The 
reaction time was relatively short and the ease of work-
up made lithium aluminium hydride reduction of the 
cyanohydrin (2.49) the preferred route to the amino-
alcohol (2.56). An attempt was made to reduce the acetate 
(2.52) with lithium aluminium hydride in toluene at 70° . 
. However, under these conditions reductive cleavage of 
the acetate ester to the cyanohydrin and ethanol 
followed by loss of hydrogen cyanide from the cyanohydrin 
occurred readily. The only product of the reaction was 
the alcohol (2.51) formed by the reduction of the ketone 
(2.45). The cyanohydrin (2.49) could not be reduc€d 
with diborane, the starting material was recovered 
almost quantitatively. The results of the attempted 
reductions of the cyanohydrin (2.49) and of its acetate 
(2.52) are summarised in Table 2.1. 
l· 
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The tosyl group of t he amino-alcohol (2.56) was 
readily cleaved with sodium in liquid ammonia to afford 
2-aminomethyl-2-hydroxyadamantan-l-ylamine (2.57) in 
quantitative yield (see Scheme 2.10). The reaction 
proceeded equally well whether the amino-alcohol or its 
hydrochloride salt was used. The diamine (2.57) reacts 
very readily with carbon dioxide and must therefore be 
stored under a carbon dioxide free nitrogen atmosphere, 
or c onverted into its dihydrochloride salt. Subsequent 
reactions of the free base were conducted under a 
nitrogen atmosphere. 
A variety of methods were investigated for the 
cyclization of the diamine (2.57) to the aminopyrimidine 
(2 . 60). The reaction offered some difficulties 
however , because the conventional synthetic methods 
were unsuccessful. Guanidine hydrochloride, §-methyl-
iso-thiouronium sulphate and cyanamide all failed to 
react with the diamine and the starting material could 
be recovered in all cases. These observations are in 
keeping with those of Geluk and cowo~kers 113 who found 
that 1-aminoadamantane did not react with cyanamide or 
§-methyl-iso-thiouronium sulphate even under vigorous 
conditions. Their observations on the lack of react-
ivity of 1-aminoadamantane toward these reagents were 
confirmed in our hands. Adamantan-1-ylguanidine could 
not be prepared by the conventional methods. It has 
114 been suggested that the unsuccessful guanidination 
of sterically hindered amines is due to steric strain 
72. 
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caused by the bulky alkyl groups. However, this 
suggestion does not explain the lack of reactivity 
of the 2-aminomethyl group of the diamine (2.57) 
toward the usual reagents for guanidination. Geluk 
113 
and coworkers successfully prepared adamantan-1-
73. 
ylguanidinc by fusion of ad:imantnn-1-ylcyanamidc with 
hl ·d 225° h·1 · h' -, 115 ammonium c ori eat C, w i e Nis imura et a&. 
prepared the guanidine from 1-aminoadamantane hydro-
o 
chloride and cyanamide at 120 C. The same procedure 
should be applicable to the preparation of the amino-
pyrimidine (2.60) . It was proposed to prepare 
cyanamides of the type (2.58) and/or (2.59) by 
treatment of the diamine (2.57) with cyanogen bromide 
in ether following the method of Geluk et al. 113 
Fusion of the hydrobromide salts of the cyanamides 
should then afford the desired aminopyrimidine (2.60). 
When the diamine (2.57) in dry ether was treated with 
a two-fold excess of cyanogen bromide a mixture of 
products was obtained from which the aminopyrimidine 
(2.60) could be isolated in a yield of 54% as its· 
picrate. It is most likely that the diamine (2.57) 
forms cyanamides by reaction with cyanogen bromide. 
Fortuitously, the free amino groups of the cyanamides 
(2.58) and (2.59) undergo an intramolecular cyclization 
with the adjacent cyanamide groups before the inter-
mediates can be "trapped" by the molecule of hydro-
bromic acid liberated by the reaction of cyanogen 
bromide with the diamine. The overall result is that 
the aminopyrimidine (2.60 ) is formed and precipitates 
as the hydrobromide salt (2.60; X-=Br-). The reaction 
is depicted in Scheme 2.10. 
The oxo analogue (2.61) was prepared in high yield 
by the reaction of the amino-ketone (2.37) with 
ethyl carbazate in refluxing ethanol. Usually the 
cyclization was incomplete in ethanol but the reaction 
could be completed by heating the mixture as a 
suspension in toluene. 
ii) P.m.r. spectra 
In the p.m.r. spectra of 1,2-disubstituted 
adamantanes, identification of the proton at C-2 and 
the bridgehead proton at C-3 is of value in structural 
verification (see Section 3)ii)). The chemical shifts 
of adamantane protons display a consistent additivity, 
each substituent influencing the resonant frequency 
of protons independently of other substituents, 941116 
14. 
a significant observation for structure determination. 
Protons adjacent to the carbonyl group of adamantan-2-one 
resonate downfield from the bulk of the adamantane 
protons (see Section 3)ii)), and these downfield protons 
should afford a good probe for measuring additivity 
effects in 1-substituted adamantan-2-ones. A knowledge 
of these effects should aid in the interpretation or the 
p.m.r. spectra of 1-substituted adamantan-2-ones and 
their hydrazones. Interpretation of the p.m.r. spectra 
of such compounds is somewhat simplified because the 
molecules possess a plane of symmetry through C-1, C-2, 
C-3, and C-6. 
'I 
75 . 
The p.m.r. spectrum o f 2-oxoadamantan-l-yl(~-toluene-
p-sulphonyl)amine (fig. 2.11) exhibits a multiplet at 
o 1.51-2.67 corresponding to the 10 methylene protons 
of the adamantane skeleton. A vicinal coupling constant 
J . 2.6 Hz between the bridgehead and methylene protons VlC 
can be observed, and is in excellent agreement with those 
94 determined by Fort and Schleyer for 1-substituted 
adamantanes. The chemical shifts for the methylene 
protons are tentatively assigned as shown in Figure 2.11. 
The bridgehead protons resonate downfield from the 
methylene protons. By a comparison of their relative 
integrals, the chemical shifts o 2.55 and o 2.75 can be 
assigned to bridgehead protons H-3, and H-5 and H-7 
respectively. The assignment of H-3 may be confirmed 
by application of the additivity principle described 
below. 
If it is assumed that the bridgehead protons o-f 
adamantane resonate at o 1.88, 94 then a measure of 
·substituent effects on the chemical shifts of bridgehead 
. 
protons in 1- and 2-mono, and 1,2-disubstituted 
adamantanes can be obtained relative to the bridgehead 
protons in unsubstituted adamantane. In adamantan-2-ones 
and -2-hydrazones and in 1-substituted adamantanes, the 
bridgehead protons are deshielded and are easily 
discernible as broad multiplets downfield from the bulk 
of the adamantane protons. For this reason they, and 
particularly H-3 can be used to measure additivity 
effects, and to aid in the assignment of chemical shifts 
for bridgehead protons. The chemical shift of the 
80 7.0 
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Fig. 2.11 P.rn.r. spectrum of 2-oxoadarnantan-1-yl 
(N-toluene-p -sulphonyl)arnine in coc1 3 at 60 MHz. 
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b r lclg e h ead p r oton 11- 3 (and 11-1) l n a d ama11tanone is 
o 2.52, a difference of 0.64 ppm from o 1.88 the 
reference point, while H-3 (and H-5 and H-7) in 
1-aminoadamantane resonates at o 2.03, a difference 
of 0.15 ppm. If the effects of the carbonyl and amino 
groups are additive then the bridgehead proton H-3 in 
2-oxoadamantan-1-ylamine should resonate 0.79 
(i. e . 0.64 + 0.15) ppm downfield from the reference 
point o 1.88, that is the calculated chemical shift of 
H-3 would be o 2.67, which is in close agreement with 
the observed value of o 2.68. The chemical shifts of 
H-3 in adamantan-2-one, and in a number of 1-substituted 
adamantanes are listed in table 2.2 along with their 
displacements (6 ) in p.p.m. relative to the reference 
o 1.88 (the chemical shift of the bridghead protons in 
adamantane). The calculated and observed chemical 
shifts of the H-3 protons in several 1-substituted 
adamantan-2-ones are shown in table 2.3. From the table 
.it can be seen that the calculated chemical shift of the 
C-3 proton in 2-oxoadamantan-1-yl(~-toluene-p -sulphonyl) 
amine is o 2 . 5 9 . It is therefore most likely that H-3 
is responsible for the observed resonance at o 2.55 
while the bridgehead protons H-5 and H-7 appear downfield 
(o 2.75), an unexpected observation but one supported b y 
relative peak heights and by additivity calculations. 
t 
'/ 8 . 
Table 2.2 
Chemical 
shif t 
of 
* H-3( 6 ) 6 ( ppm) 
adamantanone 
1-aminoadamantane 
1-( N-toluene-p -sulphonyl)-
aminoadamantane 
adamantane-1-carboxamide 
adamantan-1-ol 
2-( N-ethoxycarbonyl)-
hydrazonoadamantane 
* 
2.52 
2.03 
1.95 
2.02 
2.10 
ant i 2.72 
s yn 3.07 
displacement of the observed chemical shift of H-3 
from the chemical shift of the bridgehead proton s 
of adamantane (o 1.88). 
0.64 
0.15 
0.07 
0.14 
0.22 
0.84 
1.19 
'I 
Table 2.3 
2-oxoadaman tan-1-y la.mine 
2-oxoadamantan-1-yl( ~-toluene-
p-sulphonyl)amine 
2-oxoadamantane-1-carboxamide 
117 2-oxoadamantan-1-ol 
2-(N-ethoxycarbonyl)hydrazono-
adamantan-l-yl(N-toluene-
p-sulphonyl)amine 
79. 
Chemical shift of H-3 
Calculated 
2.67 
2.59 
2.66 
2.74 
syn 2.79 
anti 3.14 
Observed 
2.68 
2.55 
2.62 
2.75 
2.73 
3.08 
'I 
As previously mentioned, the reaction of 
ethyl carbazate with 2-oxoadamantan-1-yl( N-toluene-
p-sulphonyl)amine affords a mixture of a n t i and syn 
isomers, (2.55a) and (2.55b) respectively.t It was 
found that when this mixture was treated with acetone 
cyanohydrin followed by aqueous work the proportion 
of the more stable anti isomer increased slightly. 
Treatment of the same mixture with deuterium oxide 
and sodium deuteroxide led to a further increase in 
the proportion of the thermodynamically more stable 
80. 
anti isomer (see Fig. 2.12). The reversible addition 
of HCN, H20 or n2o to the C=N bond of the hydrazone 
enables isomerization to occur, with the more stable 
anti isomer being favoured over the sy n isomer. The 
interpretation of the p.m.r. spectrum of the hydrazone 
posed a problem in that three separate bridgehead 
proton resonances were observed. However their relative 
peak heights and additivity calculations allowed 
·assignments to be made. 2-( N-Ethoxycarbonyl)hydrazono-
. 
adamantane was prepared by the reaction of adamantap-
2-one with ethyl carbazate. As previously described 
its p.m.r. spectrum (Fig. 2.5) exhibits separate signals 
(see page 32 ) 
t The relative integrals of the methylene protons 
of the ethyl groups were used as a measure of 
the proportion of each isomer. The appropriate 
methylene protons of the anti isomer resonate at 
8 4.23 while the s y n isomer methylene group 
appears as a quartet at 8 3.65 (see experimental). 
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Fig. 2.12· P.m.r. spectrum of 2-( N-ethoxycarbonyl)hydrazono-
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for bridgehead protons adjacent to C-2. The proton 
(H-1) s yn with respect to the ethoxycarbonyl group 
appears at 8 3.07 while the proton (H-3) anti with 
respect to the ethoxycarbonyl group resonates at o 2.72. 
It is expected that the proton (H-3) of the anti isomer 
(2.55a) would resonate at lower field (o 3.08) than the 
bridgehead proton (H-3) of the syn isomer (o 2.73), and 
this can be verified by the observation of changes in 
relative peak heights on treatment of the p.m.r. sample 
with D2o. The intensity of the downfield proton signal 
increases as the proportion of anti isomer increases, 
and can therefore be ascribed to the H-3 proton of the 
anti isomer. The chemical shifts of bridgehead protons 
syn and anti to the ethoxycarbonyl group of 
2-(N-ethoxycarbonyl)hydrazonoadamantane are listed in 
Table 2.2 together with their relative displacements ( t ) 
from o 1.88. Table 2.3 exhibits the calculated and 
observed chemical shifts for the bridgehead proton H-3 
. adjacent to C-2 in the syn and anti hydrazones (2.55b) 
and (2.55a) respectively. From these·predictions, the 
observed downfield resonance (o 3.08) can be assigned 
to the proton H-3 of the anti isomer and the upfield 
resonance ( o 2.73) to the syn isomer. These assignments 
may be confirmed by o2o experiments as previously 
described (see page 80 ) . The resonance at o 2.53 
is probably due to the bridgehead protons H-5 and H-7 
(of both isomers) which would be unaffected by the 
relative orientations of the ethoxycarbonyl group. 
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The exocyclic methy J. ene protons of 2-aminomethyl-
2-hydroxyadamantan-l-yl( N-toluene-p-sulphonyl)amine 
(Fig . 2.13) and 2-aminomethyl-2-hydroxyadamantan-l-
ylamine (Fig. 2.14) appear as a doublet of doublets 
with a geminal coupling constant of 12 Hz. In the 
cyclic derivative (see Fig.2.15) however, one doublet 
is broadened. The rigid structure of the pyrimidine 
results in considerable deshielding of one of the 
geminal protons of the pyrimidine ring. Consequently 
a very large difference in chemical shift (0.8 ppm) 
between the two protons can be observed. The more 
highly deshielded proton (o 4.08) is probably the 
equatorial proton H-4. 
iii) Experimental 
2-0xotricyclo[3.3.l.1 3 ' 7 Jdecane-l-carbonyl azide 
(2-oxoadamantane-1-carbonyl azide) (2.35) 
To an ice-cold solution of 2-oxoadamantane-1-
carbonyl chloride ( 2. 9) ( 4. 5 g, 2 0 mmol) in acetone 
(15 ml) was added dropwise, a solution of sodium azide 
(2.2 g, 30 mmol) in acetone (10 ml) and water (8 ml). 
The temperature of the reaction mixture was maintained 
at 0-5° throughout the addition, with the aid of an 
ice-bath, and stirring was continued in the cold for 
0.5 h. The cold reaction mixture was extracted with 
ether (5 x 30 ml), and the combined extracts were 
washed with water (50 ml), aqueous sodium hydrogen 
carbonate (10%, 2 x 50 ml) and aqueous sodium chloride 
( 10 % , 5 0 ml ) . The dried extracts were evaporated at 
0 10-15 to afford the carLonyl azide as a white 
crystalline solid (3.87 g, 83%) melting at 63-64° (d). 
\) 2160 (N 3 ), 1720 (ketone), 1695 (carbonyl azide C=O). max 
P.m.r. c5(CDC1 3 ) 1.60-2.47 (m, 12H), 2.60 (m, Wh/ 2 6Hz, 
lH, H-3). 
2-0xotricyclo[3.3.l.1 317 ]decan-l-ylisocyanate 
(2-oxoadamantan-1-ylisocyanate) (2.36) 
2-0xoadamantane-l-carbonyl azide (2.35) (4.38g, 
20 mmol) was dissolved in benzene (100 ml) and the 
solution heated under reflux for 2 h. Evaporation of 
the solution afforded the isocyanate (3.3 g, 94%) 
which had m.p. 151.5-153° after recrystallization from 
acetone-water (Found: C, 68.9; H, 6.7; N, 7.4. 
\) 2 2 8 0 , 2 2 4 0 ( s, NCO) , 173 0 ( C=O) . 
max 
P.m.r. c5 (CDC1 3 ) 
1.50-2.63 (m, 12H), 2.87 (m, Wh/ 2 6Hz, lH, H-3). 
· 2-0xotricyclo[3.3.l.1 317 ]decan-l-ylamine 
(2-oxoadamantan-1-ylamine) (2. 37) 
2-0xoadamantan-1-ylisocyanate (2 g , 11 rnrnol) was 
dissolved in toluene (40 ml) and the solution heated 
with 4N hydrochloric acid (75 ml) on a steam bath for 
12 h. After cooling to room temperature the toluene 
layer was separated, dried, and evaporated to dryness 
to afford N , N'-di[2-oxoadamantan-l-yl]urea (2.38) 
(176 mg, 9%) identical with that described below. 
,, 
The aqueous layer was basified (pH 9) with 
SN potassium hydroxide and extracted with chloroform 
( 4 X 5 0 ml) . The combined extracts were washed with 
water (50 ml), dried, and evaporated to yield the 
* 0 amino-ketone (1.54 g; 85 %). It had m.p. 215-216 
0 
after sublimation (75 /0 .. 7 mmHg) (Found: C, 72.2; 
H, 9.2; N, 8.5. 
H, 9.2; N, 8.5%). 
c10H15N1o1 requires c, 72.7; 
v 3380, 3310, 3200 (NH str), 
max 
172 0 ( C=O) . P.m.r. cS (CDC1 3 ) 1.45-2.40 (m, 15H), 
8 8. 
1.72 (NH 2,exchanges in D2o), 2.68 (m, Wh/ 2 10 Hz, lH,H-3). 
The hydrochloride salt could be prepared simply by 
evaporating the aqueous acid to dryness. Recrystall-
ization of the residue from ethanol-ether afforded the 
amino-ketone hydrochloride as a white crystalline solid 
0 (1.96 g, 89%), m.p. 297-298 (Found: C, 59.1; H, 7.7; 
N, 6. 7; Cl, 18.0. ClOH16Nl01Cll requires C, 59.6; 
H, 8 . 0 ; N, 6. 9; Cl, 17.6%). \) 3300-2300 (br, 
max 
NH+ 
3 and CH str) , 1723 ( C=O) . 
N , N' -Di[2-oxotricyclo[3.3.l.1 317 Jdecan-l-yl]urea 
( N., N'-di [2-oxoadamantan-1-yl] urea) (2. 38) 
The isocyanate (2.36) (760 mg, 4 mmol) was dissolved 
in acetone (7 ml) and water added until cloudiness . 
persisted. The mixture was heated under reflux for 
5 min and cooled. The urea crystallized in fine needles 
..... 
u ~. 
( G J O mg , 8 9 i ) , rn c 1 t in CJ c.1 I :2 U 9 . S - 2'0 1 o ( cl ) ( 11' u u·i 1 cl : C , . / 0 • S ; 
N, 7.9%). v 3350 (NH str), 1730 (ketone, C=O), 
max 
1628, 1560 (urea). 
7 16 -D. h t l ['ll 3 3 1 3,18 1 8,12 110,14 01,6 0 8,15] , iaza ep acyc o . . . . . . . 
docosa-6(7) ,15(16)-diene (diadamantano[l,2-b :l' ,2'-e ]-
2,5-dihydropyrazine) (2.44) 
(a) 2-0xoadamantan-1-ylamine (330 mg, 2 mmol) and 
TosMIC (507 mg, 2.6 mmol) were dissolved in a mixture 
of ethanol (0.3 ml) and glyme (14 ml) and the solution 
cooled to -s 0 c. Potassium-t-butoxide (560 mg, 5 mmol) 
was added to the stirred mixture in portions over a 
period of 30 min. Stirring was continued at room 
0 temperature for 14 h. and then at 60 for 5 h. The 
suspension was filtered and the filtrate evaporated to 
dryness to afford a white solid. Recrystallization 
0 from petroleum ether (b.p. 40-60) gave the 
.dihydropyrazine (267 mg, 91%), m.p. 236-238° (Found: 
c, 82.0; H, 9.2; N, 9.3. c20H26 N2 requires C, 81.6; 
H, 8.9; N, 9.5%). V 16 7 4 ( C=N) , 14 5 4 , 1176 , 9 0 4 . 
max 
P.m.r. 8 (CDC1 3 ) 1.53-2.33 (m, 24H), 2.53 (m, Wh/ 2 12 Hz, 
2 H , H - 3 , H - 3 ' ) ; m/ e 2 9 4 (M + • 10 0 % ) . 
( b) A solution of the amino-ketone ( 8 2. 5 mg, o .. 5 rnrol) 
in benzene (7 ml) was heated under reflux with slow and 
continuous distillation of the solvent. The volume of 
the solution was maintained by the occasional addition 
of dry benzene. After 1.5 h the starting material had 
almost completely disappeared (infra-red). Evaporation 
..... 
of the solvent and recry s tallization of the r e sidue 
0 from petroleum ether (b.p. 40-60) afforded the 
dihydropyrazine identical with that described above. 
9 0. 
(c) The amino-ketone (82.5 mg, 0.5 rnrnol) in glyme 
(5 ml) was treated with potassium-t-butoxide (56 mg, 
0.5 rnrnol) and the mixture heated under reflux for 7 h. 
The solution was filtered and the filtrate evaporated 
to dryness to afford the dihydropyrazine identical with 
that from~) and (b). 
(d) A mixture of 2-oxoadamantane-1-yl( N-toluene-p -
sulphonyl)amine (2.45) (128 mg, .4 rnrnol) and TosMIC 
(100 mg, 0.5 rnrnol) in ethanol (0.1 ml) and glyme (4 ml) 
was treated with potassium-t-butoxide (112 mg, 1 rnrnol) 
according to the method described in (a). The residue 
from evaporation of the filtered reaction mixture was 
washed with a small quantity of cold methanol and the 
remaining white solid dissolved in ether. Evaporation 
of the filtered ethereal solution afforded the starting 
material (94 mg, 73%). The insoluble material (20 mg, 
17%) was found to be identical with the dihydropyrazine 
described above. 
2-0xotricyclo[3.3.l.1 3 ' 7 Jdecan -1-yl( N-toluene-p=-
sulphonyl)amine (2-oxoadamantan-1-yl( N-toluene-p -
sulphonyl)amine) (2.45) 
The amino-ketone (2.37) (4.98 g, 30 rnrnol) was added 
to pyridine (25 ml) containing toluene-p -sulphonyl 
chloride (11.4 g, 60 rnrnol) and the mixture stored in 
the cold. After 48 h the mixture was poured into 
.... 
.. 
ice-cold water and the c r ystalline solid that 
separated was collected, washed with water and dried. 
The toluene-p-sulphonyl derivative (8.23 g, 86%) was 
recrystallized from ether and had m.p. 162-164° 
(Found: C, 64.2; H, 6.6; N, 4.3; S, 9.7. 
S, 10.0%). v 3322 (NH str), 1724 (C=O). 
max 
P.m.r. 
91 . 
o(CDC1 3 ) 1.51-2.67 (m, lOH), 2.36 (s, 3H, toluene, cH 3 ), 
2.55 (m, 2H, H-5 & H-7), 2.75 (m, lH, H-3), 
6.21 (br, s, lH, NH), 7.48 (q, aromatic H). 
2-Hydroxy-2-cyanotricyclo[3.3.l.1 317 Jdecane 
(2-hydroxy-2-cyanoadamantane) (2.40) 
Adamantanone (4 g, .027 mol) was dissolved in 
acetone cyanohydrin (25 ml) and triethylamine 
(25 drops). The mixture was kept under nitrogen in 
the cold for 24 h before being poured into ice-cold 
water. The precipitated solid was collected, washed 
with water and dried. Recrystallization from 
petroleum ether (b.p. 60-80°) afforded the cyanohydrin 
(4.3 g, 91%), m.p. 231-233° (lit. 86 232-233.5°) (Found: 
C, 7 4. 7; H, 8. 7; N, 8 . 0 . Cale. for CllH15NlOl: 
C, 7 4. 5; H, 8. 5; N, 7.9%). V 3420 (OH str) , 
max 
2235 ( CN) . P.m.r. o ( CDCl 3 ) 1.35-2.40 (m' 14H) , 
3.70 ( s ' lH, OH) . 
..... 
,, 
92. 
15-Cyano-7, 16-diazahe ptacyc lo lll .·3. 3. 1 3 ' 18 . i-8 ' 12 . 11 0 ' 1 '1. 
1 6 8 15 . 0 ' .O' ]docos-6(7)-ene (3-cyano-diadamantano[l,2-b : 
l' , 2 '- e ] 2, 3, 4, 5-tetrahydropyrazine) ( 2. 4 8) 
The amino-ketone (2.37) (200 mg, 1.2 mmol) was 
dissolved in acetone cyanohydrin (3 ml) and triethylamine 
(2 drops) added. The mixture was stored under nitrogen 
in the cold for 2 days. Evaporation of the solution at 
30-35° under a stream of nitrogen afforded an oily solid, 
which on trituration with ether gave a white solid. 
The product recrystallized from ether in colourless 
elongated plates (148 mg, 77%), m.p. 243-244.5° (d) 
(Found: C, 7 8. 7; H, 8 . 6 ; N, 12. 9. C21H28N3 requires 
C, 7 8. 5; H, 8 . 5 ; N, 13.1%). \) 3 32 0 (NH str) , 
max 
2200 ( CN) , 1655 ( C=N) . m/e 321 (M+• 5 % ) ' 294 (100 %) 
2-Cyano-2-hydroxytricyclo[3.3.l.1 3 ' 7 Jdecan -1-yl 
(N-toluene-p -sulphonyl)amine (2-cyano-2-hydroxy-
adamantan-l-yl( N-toluene-p -sulphony l)amine) (2.49) 
The tosylamino-ketone (2.45) (2.5 g, 7.8 mmol) 
was dissolved in acetone cyanohydrin (50 ml) and 
triethylamine (30 drops) and stirred under nitrogen 
in the cold for 2 days. The mixture was poured into 
ice-cold water and the sol i d collected a nd washed with 
water. The cyanohydrin (2.59 g, 96 %) was rec r ystall-
o ized from ether and had m.p. 163-1 65 (d ) (Found: 
requires C, 62.4; H, 6.4; N, 8.1; S, 9.3 %). 
v 3379 (OH str), 324 2 (NH str), 2250 (CN). P.m.r. 
max 
cS(CDC1 3 ) 1.2-2.67 (m, 13H), 2.40 (s, 3H, CH 3 ), 
5 . 0 2 ( br, s, lH, OH) , 5 . 7 7 ( br, s, lH, NH) , 
7.53 (q, 4H, aromatic H). 
9 3. 
2-Acetoxy-2-cyanotricyclo[3.3.l.1 3 ' 7 Jdecan-l-yl 
(N-toluene-p-sulphonyl) amine (2-·acetoxy-2-
cyanoadamantan-l-yl (N-toluene-p-sulphonyl) amine.) ( 2. 52) 
The cyanohydrin (2.49) (1 g, 2.8 mrnol) was dissolved 
in a mixture of acetic anhydride (4.6 g) and pyridine 
( 5. 8 ml) . After standing at room temperature for 24 h 
the solution was poured into ice-cold water. The 
aqueous suspension was extracted with chloroform 
(5 x 40 ml) and the combined chloroform extracts washed 
with water, 2N HCl, 10% aqueous potassium carbonate and 
again with water. Evaporation of the dried extracts 
afforded a colourless semi-solid which when triturated 
with ether gave the acetate (980 mg, 88 %), m.p. 
0 224.5-226 (Found: C, 61.6; H, 6.6; N, 6.9; S, 8.1. 
c20 H24 N2s1o4 requires C, 61.8; H, 6.2; N, 7.2; · 
S , 8 . 3 % ) . v 3 2 5 0 ( NH s tr) , 1761 ( C=O) . P. m. r. 
max 
cS(CDC1 3 ) 1.40-2.32 (m, 12H), 2.08 (s, 3H, acetate CH 3 ), 
2.42 (s, 3H, toluene CH 3 ), 2.93 (br s, lH, H-3), 
5. 75 (s, lH, NH), 7 .63 (q, 4H, aromatic H). 
-
'I 
2-(N-Etho~ycarbonyl)hydrazonotricyclo[3.3.l.1 3 ' 7 ] 
decan-1-yl(N-toluene-p-sulphonyl)amine (2-(N-ethoxy-
carbonyl)hydrazonoadamantan-1-yl(N-toluene-p-
sulphonyl) amine) ( 2. 5 5) 
94. 
The N-tosylamino-ketone (2.45) (200 mg,0.63 rnrnol) 
in ethanol (3 ml) and a trace of acetic acid (1 drop) 
was treated with ethyl carbazate (66 mg, 0.63 rnrnol) and 
the mixture heated under reflux for 16 h. Evaporation 
of the solution gave the hydrazone (232 mg, 91%), m.p. 
169.5-171° after recrystallization from ethanol 
(Found: C, 59.0; H, 6.8; N, 10.1; S, 7.7. 
S, 7 . 9%). v 3460, 3350 (NH str), 1738 (C=O), 
max 
1530 (C=N). P.m.r. c5 (CDC1 3 ) 1.33-2 .60 (m, 12H), 
1.15 (t, 1.4 H, CH 2 CH 3 syn), 1.27 (t, 1.6H ,CH2 cH3 
anti), 2.32 (s, 3H, toluene CH 3 ), 2.53 (m, 2H, H-5 & H-7, 
2 . 73 (m, Wh/ 2 8 Hz, .47H, H-3 syn), 3.08 (m, wh/2 9 Hz, 
.53H , H-3 anti), 3.65 (q, .95H, CH 2cH 3 , syn), 4.23 
(q, 1.05H, CH
2
CH 3 , anti), 6.95 (s, lH, NHTs), 7.50 
(q, 4H, aromatic H), 7.78 (br s, lH, NNH). 
2-Arninomethyl-2-hydroxytricyclo[3.3.l.1 3 ' 7 ]decan-l-yl 
(N-toluene-p-sulphonyl)amine (2-aminomethyl-2-hydroxy-
adamantan-l-yl (N-toluene-p-sulphonyl) amine) (2. 56) 
(a) With platinum oxide: The N-tosylamino 
cyanohydrin (2.49) (1.15 g, 3.3 rnrnol) was dissolved in 
ethanol (30 ml) and ethanolic HCl (3.2 N, 5 ml), and 
platinum oxide (570 mg) was added. The mixture was 
I 
I 
ft 
95. 
hydrogenated at 4 atmos pheres for 2.5 days after which 
time a further quantity of platinum oxide (570 mg) was 
added and hydrogenation continued for 2 days. 
Ethanol was added to dissolve the solid and the 
solution was filtered and reduced in volume to 30 ml 
at room temperature. Ether was added and the white 
precipitate was collected. Recrystallization from 
ethanol-ether afforded the amino-alcohol hydrochloride 
(1.06 g, 73%), m.p. 274-275° (Found: N, 7.3; Cl, 9.2. 
+ 3660-2600 (NH 3 , OH and CH str). 
\) 
max 
1.12-2.60 (m, 14H), 2.40 (s, 3H, toluene CH 3 ), 
3.60 (s, 2H, CH 2NH 2 .HC1), 7.68 (q, 4H, aromatic H). 
Evaporation of the mother liquors and fractional 
crystallization of the residue from ether gave the 
N-tosylamino-ketone (2.45) (84 mg, 7%), identified by 
comparison with an authentic sample, and the alcohol 
(2.51) (167 mg, 14%), identical with that described 
in (c) . 
(b) With "Vitride" (NaAlH 2 (OCH 2CH 20CH 3 ) 2 ): The 
cyanohydrin (346 mg, 1 rnmol) in dry benzene (5 ml) was 
treated with "Vitride" (2 ml) in benzene (5 ml) and the 
mixture was allowed to stand at room temperature for 18 h. 
To the solution was added saturated aqueous sodium 
carbonate and the mixture heated on a steam bath for 
5 min. The solution was then extracted with chloroform. 
The extracts were dried (Na 2so4 ), filtered, and the 
filtrate evaporated to afford an oil. Ether was added 
-
I: 
.. 
and the product collect d . It was f ound t o be 
identical with the amino-alcohol (2.56) (158 mg, 45 %) 
described below. Evaporation of the mother liquors 
gave the alcohol (2.51) (164 mg, 51 %) which was 
identical with that described below. 
9 G • 
(c) With lithium aluminium hydride: The cyanohydrin 
(1.3 g, 3.8 rnmol) in glyme (15 mls) was treated with 
lithium aluminium hydride (400 mg) and the mixture 
stirred at room temperature for 24 h. To the solution 
was added saturated aqueous sodium carbonate and the 
mixture was stirred for 30 min. The solution was then 
extracted with chloroform. The extracts were dried 
(Na2so4 ), filtered and the filtrate evaporated. Ether 
(250 ml) was added to the oily residue and the 
crystalline amino-alcohol (891 mg, 67 %) was collected, 
0 
m.p. 133-134 (Found: C, 61.8; H, 7.3; N, 7.7; 
S, 9.1. 
N, 8.0; S, 9.2 %). v 3427 (OH str), 3290 (NH str). 
max 
P.m.r. c5 (CDC1 3 ) 1.35-2.13 (m, 13H), 2.40 (s, 3H, 
toluene CH 3 ) , 2. 55, 3. 4 9 (dd, J 12 Hz, 2H, - CH 2NH 2.) , 
3.35 (m, 4H, NH , OH , NH 2 ), 7.55 (q, 4H, aromatic H) . 
Evaporation of the filtrate afforded the alcohol (2.51) 
(338 mg, 28%) identical to that described in (e). 
(d) With diborane: The cyanohydrin (173 mg, 0. ·5 
mmol) in glyrne (2.5 ml) was treated with dibo r ane 
(lM in THF, 1.5 ml). After 2 hat room temperature, 
excess diborane was decomposed with ethanol. Ethanolic 
hydrogen chloride (1.5 ml) was added and the solution 
evaporated. The residue was partitioned between 
chloroform and 4N aqueous ammonia. Evaporation of 
the dried chloroform extracts afforded the starting 
material (163 mg, 94%). 
Reduction of 2-acetoxy-2-cyanoadamantan-l-yl 
(N-toluene-p-sulphonyl)amine (2.52) 
97. 
The acetate (2.52) (388 mg, 1 mmol) in refluxing 
toluene was treated with lithium aluminium hydride 
(750 mg), and heating and stirring continued for 18 h. 
The usual work-up afforded the alcohol (2.51) (298 mg, 
93%) which had m.p. 186.5-187.5° after recrystallization 
from ether (Found: C, 6 3. 1; H, 7. 0; N, 4 . 4 ; S, 10. 0. 
c17H23 N1 s1o3 requires C, 63.5; H, 7.2; N, 4.4; 
S, 10. 0%). \J 3580 (OH str), 3250 (NH str). 
max 
P.m.r. c5(CDC1 3 ) 1.12-2.25 (m, 13H), 2.38 (s, 3H, 
toluene CH 3 ), 3.85 (d, J 3 Hz, lH, H-2), 3.33-5.33 
(br, lH, NH), 7.59 (q, 4H, aromatic H). 
2-Aminomethyl-2-hydroxytricyclo[3.3.1~13 ' 7 ]decan-l~ 
ylamine (2-aminomethyl-2-hydroxyadamantan-l-ylamine) 
(2.57) 
2-Aminomethyl-2-hydroxyadamantan-l-yl( N-toluene-
p-sulphonyl)amine (2.56) hydrochloride (500 mg, 1.29 mmol) 
in liquid ammonia (15 ml) was treated with sodium in 
small amounts until the blue colour persisted for at 
least 10 min. After standing for 20 min, ammonium 
chloride was added and the ammonia allowed to evaporate. 
The residue was partitioned between 2N sodium 
hydroxide (30 ml) and chloroform and the dried 
chloroform extracts afforded, on evaporation, the 
diamine (250 mg, 98%), m.p. 133-134°. P.m.r. 
9 U. 
o(CDC1 3 ) 1.33-2.53 (m, 18H, adamantyl, NH 2 , OH protons), 
2.74, 3.20 (dd, 2H, J 12 Hz, CH 2NH 2 ). The dihydro-
chloride had m.p. 340-343° (d) (Found: C, 48.7; H, 8.4; 
N, 10.0; Cl, 26.2. 
H, 8.2; N, 10.4; Cl, 26.3%). v 3610-2480 
max 
+ + (br, NH 3 , OH, CH str), 2020 (NH 3 ) . 
. 7 11 1 6 6-Hydroxy-2,4-diazatetracyclo[7.3.l.l ' .0' ]tetra-
decane-3-iminium (5-hydroxytetrahydroadamantano[l,2-d ] 
pyrimidine-2-iminium)picrate (2.60) 
To the diamine (2.57) (250 mg, 1.28 mmol) in ether 
(10 ml) was added cyanogen: bromide (297 mg, 2.6 mmol) in 
ether (15 ml) with stirring. A white precipitate 
formed and stirring was continued for 30 min. The wh ite 
solid was collected and dried in vacuo . The picrate 
( 3 3 4 mg , 5 8 % ) had m. p. 2 61-2 6 2 . 5 ° ( Found : C , 4 8 . 0 ; H , ~ . 2 ; 
N, 18.7. 
N, 18.7%). 
c18H22 N6o8 requires c, 48.0; H, 4.9; 
v 3 4 31 , 3 3 5 0 , 3 214 (NH, OH s tr) , 
max 
1679, 1624 (cyclic guanidino). 
1.47-2.67 (m, 13H), 3.28 and 4.08 (dd, J 12, 2H, H:...4). 
2,4,5-Triazatetracyclo[ 7 .3.l.1 7 i 11 .o1 ' 6 Jte~radec-
4 ,5-en-3-one (adamantano [2 ,1-e]-triazin -2-one) (2. 61) 
A solution of the amino-ketone (2.37) (330 mg, 
2 rmnol) and ethyl carbazate (208 mg, 2 rmnol) in 
ethanol (3 ml) was heated under reflux for 6 h. The 
solution was evaporated to dryness and the residue 
99. 
suspended in toluene (5 ml). The mixture was heated 
under reflux for 30 min and the triazine (322 mg, 80%) 
was collected. 0 It had m.p. 356.5-358 after 
recrystallization from ethanol (Found: C, 64.3; 
H, 7.3; N, 20.4. 
H, 7.4; N, 20.5%). 
c11H15N3o1 requires c, 64.4; 
\) 3260, 3080 (NH str), 
max 
16 9 9 ( C=O) , 16 6 5 ( C=N) . 
5) Photochemical Syntheses of 1,2-disubstituted 
adamantanes 
i) Discussion 
A number of other methods were investigated for 
the preparation of 1,2-disubstituted adamantanes as 
precursors to the isomeric adamantanopyrimidines 
described in Part 2, Sections 3 and 4). As previously 
mentioned (Section 2), several successful approaches 
to the synthesis of 1,2-disubstituted adamantanes have 
utilized intramolecular cyclization reactions of 
nitrenes. These reactions ~ere studied with a view 
toward the preparation of 1,2-disubstituted adamantanes 
appropriate to the present work. 
....... 
100. 
d A . 64 , G~ h d Curran an ngier ave prepare 
adamantano[2,l-d]oxazolidin-2-one (2.66) in 45% yieldby 
photolysis of adamantan-1-yloxycarbonyl azide (2.65) 
in cyclohexane. The second product, cyclohexyl 
carbamate (2.67), was formed by insertion of the 
intermediate nitrene into a C-H bond of the solvent 
and was isolated from the reaction mixture in a yield 
of 4%. Both the oxazolidinone (2.66) and the 
cyclohexyl carbamate (2.67) are presumably formed V&a 
· 1 · · d' 118,119,120 the sing et state nitrene interme iate, 
rather than a triplet state nitrene. We were able to 
increase the yield of the oxazolidinone (2.66) to 65% 
by photolyzing the azide (2.65) in more concentrated 
cyclohexane solutions. Under such conditions the 
analytically pure product separates out of solution 
and is easily collected. The remaining product can be 
recovered by evaporating the solution and triturating 
the oily residue with cold cyclohexane. In 1974, 
Alewood and coworkers 67 obtained the oxazolidinone 
. 
(2.66) in high yield (86%) by thermal decompositioq of 
the azide (2.65) in chloroform containing a trace of 
ethanol. A small quantity of adamantan-1-yl N-ethoxy 
carbamate 67 was isolated from the reaction mixture and 
was probably formed by reaction of the nitrene with 
ethanol in the thermolysis. 
Adamantan-1-yloxycarbonyl azide (2.65) was prepared 
by the sequence of reactions illustrated in - Scheme 2.11. 
Treatment of adamantan-1-ol (2.62) with phosgene in 
toluene and pyridine in a modification of the method of 
~ 
OH 
(2.62) (2.63) 
NHTs 
~ 
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l 
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Kcvill and Weitl, 12 1 a f fo 1d c d ada1~antan-l-yl ~xycarbony l 
chloride (2.63). The yields are variable however, and 
1-chloroadamantane could occasionally be isolated from 
the reaction mixture and probably results from thermal 
decomposition of the oxycarbonyl chloride. 121 The 
preparation of adamantan-1-yl p -nitrophenyl carbonate 65 
from adamantan-1-ol and p-nitrophenyl chloroformate is 
a more reliable reaction than the chloroformylation of 
adamantan-1-ol, and the carbonate is therefore the 
preferred intermediate for the preparation of 
adamantan-1-yloxycarbonyl hydrazide (2.64). However, 
in this work the oxycarbonyl hydrazide (2.64) was 
prepared from the oxycarbonyl chloride (2.63) by treatment 
. h h d . 128 h b 1 h d 'd wit y razine. Te oxycar ony y razi e was 
converted into adamantan-1-yloxycarbonyl azide (2.65) 
with nitrous acid according to the method of Gerzon and 
122 Krumkalns. An attempt was made to convert the 
oxycarbonyl chloride (2.63) into the azide (2.65) 
directly using lithium azide or sodium azide but the 
reaction was incomplete after 48 h, and large quant~ti e s 
of 1-chloroadamantane could be detected in the products. 
Kevill and Weitl 123 however were able to prepare 
adamantan-1-yloxycarbonyl azide (2.65) from the 
oxycarbonyl chloride and sodium azide. The azide {2.65) 
was isolated in 52% yield by column chromatography, but 
the yield was lower than the yield of 92 % (based on the 
oxycarbonyl chloride) by the method of Gerzon and 
Krumkalns 122 in our hands. 
103 . 
.. 
Hydrolysis of the ox a zolidinone (2.66) in 2N 
hydrochloric acid according to the procedure of Curran 
. 64 65 
and Angier ' afforded 2-aminoadamantan-1-ol 
hydrochloride (2.68) (see Scheme 2.11). The availability 
of the amino-alcohol (2.68) made it a promising precursor 
to the adamantanopyrimidine (2.30) and the proposed 
synthetic route to the analogue is illustrated in 
Scheme 2.12. Attempts to convert the 1-hydroxy group 
(by bromo or tosyloxy substitution) to yield 
2-aminoadamantane-1-carbonitrile (2.71), the intended 
intermediate for the preparation of the diamine (2.29) 
were uniformly unsuccessful . Treatment of the 
oxazolidinone (2.66) or 2-aminoadamantan-l-ol (2.68) 
with fuming hydrobromic acid afforded mixtures of 
2-aminoadamantan-1-ol (2.68) and l-bromoadamantan-2-yl 
amine (as determined by mass spectrometry) as their 
hydrobromide · salts. In view of the forcing conditions 
required to substitute tertiary adamantanyl bromides 
· ·d 1 h ' l 124 · d · d d b d 
-with a cyani e nuc eop i e it was eci e to a an on 
. 
this approach. Although it is well known that 
adamantan-1-yl toluene-p -sulphonate hydrolyses very 
rapidly to adamantan-1-ol with traces of water, 125 it 
was planned to tosylate the amino-alcohol (2.68) and to 
substitute the 0-tosyl group with the cyanide nucleophile. 
It was envisaged that hydrolysis of the tosyloxy group 
would be hindered by the adjacent amino group. Tosyl-
ation of 2-aminoadamantan-1-ol in pyridine, however, 
afforded only the N-tosyl derivative (2.69) (Scheme 2.11). 
~ 
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The 0-tosyl group was cleurly hydrolyz e d extremely 
rapidly on contact with moisture and the vicinal amino 
group did not hinder the hydrolysis of the tosyl group. 
This route was therefore not pursued further. 
The possibility of preparing the isomeric analogue 
(2.82) from l-aminoadamantan-2-ol (2.78) was also 
investigated. Greidanus 66 had photolyzed adamantan-2-
yloxycarbonyl azide (2.75) by a procedure analogous to 
th 1 db C d A . 64,65 . h h . at emp oye y urran an ngier int e synt esis 
of the isomeric oxazolidinone (2.66). He isolated two 
products, adamantan-2-yl N-cyclohexylcarbamate (41%) and 
an heterocyclic oxaza compound (15 %). He could not 
assign with certainty the structure of the latter 
compound, but proposed the structures (2.76) and (2.79). 
However, his elemental analysis and infrared spectrum 
-1 (strong carbonyl absorptions at 1715 and 1755 cm. , 
five membered cyclic carbamate), but not the p.m.r. 
spectrum, support the oxazolidinone structure (2.76). 
Adamantan-2-yloxycarbonyl azide (2.75) was prepared 
in this work from adamantan-2-ol (2.72) according to the 
sequence of reactions illustrated in Scheme 2.13. This 
sequence differed from that used by Greidanus, which 
proceeded via the p-nitrophenyl carbonate rather than 
the acid chloride (2.73). Photolysis of the azide · 
(2.75) in cyclohexane afforded the oxazolidinone (2.76) 
in 21% Yield, and adamantan-2-yl N-cyclohexylcarbamate 
(2. 77) (31% yield). When dichloromethane was used as 
the solvent, to avoid the formation of the solvent 
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insertion product (2.77), a 9% yield of the oxazolidinone 
(2.76) was obtained together with an intractable tar. 
Thus, in cyclohexane the solvent insertion product (2.77) 
was the major component, while in dichloromethane a brown 
tar was obtained from which the oxazolidinone (2.76) 
could be isolated by chromatography on alumina. 
The p.m.r. spectrum of the oxazolidinone (2.76) has 
two peaks representing the NH proton and the proton at 
C-2, as well as a multiplet for the remaining protons. 
(The p.m.r. spectra of the oxazolidinone (2.76) and the 
cyclohexylcarbamate (2.77) are discussed in greater 
detail in Section 5 (ii) The spectrum reported by 
Greidanus 66 for the heterocyclic oxaza compound showed 
four minor peaks representing a total of two protons, 
in addition to the 13 proton multiplet due to the bulk 
of the adamantane protons. It is now clear that the 
p.m.r. spect~um of the product reported is in fact that 
of a 1:1 mixture of the oxazolidinone (2.76) and the 
·cyclohexylcarbamate (2.77) (see Section 5 (ii)). 
The formation of the oxazin-2-one (2.79) would 
appear unfavourable in view of the preference of 
acylnitrenes for insertion into the bridgehead rather 
than the methylene C-H bonds of adamantane. The 
structure of the oxazolidinone (2.76) was confirmed· 
beyond doubt by hydrolysis to l-aminoadamantan-2-ol 
hydrochloride (2.78) which was identical with the 
amino-alcohol obtained by the reduction of 
2-oxoadamantan-1-ylamine (2.37) with lithium aluminium 
hydride. Moreover, the amino-alcohol (2.78) obtained 
by reduction of the amino -ke tone (2.37) could be 
converted with phosgene in toluene and 2N sodium 
hydroxide into a compound having melting point, and 
infrared and p.m.r. spectra identical with those of 
the oxazolidinone (2.76). 
10~. 
The nitrene formed by the photolysis of 
adamantan-2-yloxycarbonyl azide (2.75) has two possible 
C-H bonds into which it may insert, assuming that the 
reaction takes place at the C-H bonds adjacent to the 
substituent. Nitrenes derived from the photolysis of 
adamantan-1-yloxycarbonyl azide (2.65) on the other 
hand have six adjacent C-H bonds into which they may insert. 
From a statistical point of view, the formation of 
adamantano[2,1-d]oxazolidin-2-one (2.66) by photolysis 
of adamantan-1-yloxycarbonyl azide (2.65) in solvents 
capable of trapping the intermediate nitrenes (e. g . 
cyclohexane) · should be relatively more favourable than 
the formation of adamantano[l,2-d]oxazolidin-2-one (2.76) 
-by photolysis of adamantan-2-yloxycarbonyl azide (2.75) 
under the same conditions. That is, ~he relative 
proportions of oxazolidinone and carbamate will be 
different in both cases, and statistical factors will 
result in a larger proportion of the intramolecular 
cyclization product from the photolysis of adamantan-1-
yloxycarbonyl azide (2.65) because of the greater 
abundance of adjacent C-H bonds. However, oxycarbonyl 
nitrenes show a considerable preference for insertion 
I . 
11 0. 
-into bridgehead C-H bonds of adamantane* and it was 
hoped that this factor would counteract the statistical 
bias against the formation of the oxazolidinone (2.76) 
sufficiently to result in a good yield. 
was not observed experimentally. 
This, however, 
From the results described above it can be seen that 
the photolysis of adamantan-2-yloxycarbonyl azide (2.75) 
was an unsatisfactory method for the preparation of 
adamantano[l,2-d]oxazolidin-2-one (2.76). Alewood and 
67 
coworkers however, were able to prepare the oxazolidinone 
(2.76) in high yields by thermal decomposition of the 
oxycarbonyl azide (2.75) in chloroform. 'd 66 d Grei anus an 
67 Alewood and coworkers have also considered the cycliz-
ation of the intermediate nitrene to the tetrahydro-1,3-
oxazin-2-one (2.79), but Alewood et al . were unable to 
detect any of the oxazin-2-one (2.79). Greidanus however 
was unable to assign the structure (2.76) to the intra-
molecular nitrene insertion product with certainty 
{see page 113). 
Hydrolysis of the oxazolidinone (2.76) in 60 % 
hydrobromic acid afforded a mixture of l-amino-adamantan-
2-ol (2.78) and l-aminoadamantan-2-ylbromide (as 
determined by mass spectrometry). This observation is 
not unusual in view of the results described previously 
(see page 103) and the difficulties encountered by 
80 Tabushi and Aoyama in replacing the hydroxy group of 
adamantan-2-ols with bromine. 
* Ethoxycarbonylnitrenes were found to be six times more 
reactive toward the tertiary C-H bonds than the secondary 
C-H bonds of adamantane.126 
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112. 
It was planned to t o s ylate the arnino- a ltoho l (2.78) 
and to substitute the 0-tosyloxy group with a cyanide 
nucleophile . The aminonitrile (2.43) would then be a 
suitable precursor for the adamantanopyrimidine (2.82), 
and the proposed reaction sequenc e is illustrate d in 
Scheme 2.14. Difficulties were encountered in the 
substitution of adamantan-2-yl toluene-p -sulphonate wi t h 
the cyanide nucleophile . An investigation of the 
substitution of the 0-tosyloxy group with cyanide was 
carried out in a variety of solvents. Usually the 
hydrolysis product, adamantan-2-ol predominated, and 
2-cyanoadarnantane was not isolated. It is also possible 
that rearrangement products were formed, for example 
Lenoir and coworkers127 have isolate d exo -proto-
adamantanyl-4-acetate following the acetolysis of 
adarnantan-2-yl toluene-p -sulphonate. Because of the 
lack of success in these reactions, the route was 
abandoned. 
The moderate yields of the oxazolidinones (2.66) 
and (2.76), the numerous synthetic difficulties 
encountered, and the development of a more versatile 
route to the appropriate intermediates for the synthese s 
of adamantanopyrimidines (2.30) and (2.82), made the 
photochemical routes less attractive and they we r e . 
therefore abandoned. 
' I 
ii) P.m.r. spectra 
In the foregoing discussion the expected p.m.r. 
spectrum of adamantano[l,2-d]oxazolidin-2-one (2.76) 
was described. It should exhibit a thirteen proton 
multiplet for the adamantane protons and a broad 
signal for the single NH proton which should be 
exchangeable in deuterium oxide. The fourteenth 
113. 
proton, at C-2, can be expected to appear as a doublet 
(J 213 ~ 3 Hz) downfield from the bulk of the adamantane 
protons. The observed p.m.r. spectrum (Fig. 2.16) of 
the oxazolidinone (2.76) is consistent with the 
predicted spectrum described above, and is identical 
with the p.m.r. spectrum of adamantano[l,2-d]oxazolidin-
67 2-one (2.76) reported by Alewood and coworkers. 
·d 66 d h h Grei anus however, reporte tat t e p.m.r. spectrum 
of the oxazolidinone (2.76) exhibits four minor peaks 
in addition to the massive adamantane multiplet 
(o 1.1 - 2.6, 13H). The minor peaks resonated at 
8 6.22, 5.14, 4.79 and 4.11, and represent a total 
of 2 protons. The peaks at o 5.14 and 4.78 are 
reportedly exchangeable in deuterium oxide - sodium 
deuteroxide and are broad. A comparison of the 
66 
reported spectrum of the oxazolidinone with the · 
p.m.r. spectra of adamantan-2-yl N-cyclohexylcarbamate 
(Fig. 2.17) and adamantano[l,2-d]oxazolidin-2-one 
(Fig. 2.16) would appear to indicate that the p.m.r. 
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d b 'd 66 spectrum reporte y Grei anus is in fact that 
of a 1/1 mixture of the oxazolidinone (2.76) and 
the cyclohexylcarbamate (2.77). The chemical 
shifts of the NH protons in the spectra of both 
compounds are conceHtration dependent which would 
account for any differences between the composite 
spectrum (Fig. 2.16 + Fig. 2.17) and that reported 
by Greidanus. 
The p.m.r. spectrum of the isomeric 
adamantano[2,l-d]oxazolidin-2-one (2.66) is shown 
in Fig. 2.18. The proton at C-2 is readily 
discernible but is slightly broadened by coupling 
with the adjacent NH proton. The NH proton appears 
as a broad downfield signal and the bulk of the 
adamantane protons appear between 8 1.3 and 2.5 
(13 protons). 
The p.m.r. spectra of 1- and 2-mono, and 
1,2-disubstituted adamantane compounds prepared 
in this section are typical of each class of 
compound (for example see Part 2, Section 3(ii)). 
117. 
iii) Experimental 
Tricyclo[3.3.l.1 3 ' 7 ]dec-l-yloxycarbonyl chloride 
( adamantan-1-yloxycarbonyl chloride) ( 2. 6 3) 
118. 
The oxycarbonyl chloride was prepared by a modific-
ation of the procedure of Kevill and Weitl. 121 To a 
solution of phosgene in toluene (150 ml, 25%) at 5-10° 
was added a solution of adamantan-1-ol (10 g, 65 mmol) 
in ether (300 ml) containing pyridine (8.8 g) over a 
period of 1 h. with vigorous stirring. After stirring 
at room temperature for several hours the mixture was 
filtered and the filtrate shaken with ice-cold water. 
The organic layer was dried (Na 2 so4 ) and evaporated to 
dryness at room temperature. The residue was recry-
0 
stallized from n-hexane (-20) to afford the oxycarbonyl 
chloride (10.6 g, 75%) m.p. 48-50° (d) (lit. 121 50-51° 
(d), lit. 1221128 46-47°) \l 1770 (C=O), 1155 (C-0), 
max 
840, 809, and 696 (C-Cl). 
Attempts to evaporate the filtrate at elevated 
temperatures caused the oxycarbonyl chloride to decompose 
with consequent formation of 1-chloroadamantane, m.p.* 
164-165° (lit. 129 165°) (Found: Cl, 20.4. Cale. for 
Tricyclo[3.3.1.1 317 Jdec-l-yloxycarbonyl hydrazide 
( adaman tan-1-yloxycarbonyl hydra z ide) ( 2. 6 4) 
The oxycarbonyl hydrazide was prepared according to 
128 0 0 the method of Haas et al. (97~), m.p. 135.5 - 138 
(lit. 128 141-142°). 
Tricyclo[3.3.l.1 317 Jdec-l - yloxyca;bonyl a z i d~· 
(adamantan-1-yloxycarbonyl azide) (2. 65) 
119. 
The azide was prepared according to the procedure 
of Curran and Angier, 65 but with the modification that 
extractions were done with cold cyclohexane and solvents 
. 0 
were evaporated at 5-10 . The product was isolated as 
0 
a colourless crystalline solid (95 %) m.p. 40-42 (d) 
(1 . 123 43 440) ( d . 65 d it. - Curran an Angier o not appear to 
have prepared the azide in pure form or to have 
characterized it). v 2200 & 2140 (N 3), 1725 (C=O). max 
6 10 1 5 . 2-0xa-4-azatetracyclo[6.3.l.l ' .0' ]tridecan-3-one 
(adamantano[2,l-d ]oxazolidin-2-one (2.66) 
Adamantan-1-yloxycarbonyl azide (5 g, 22.6 mmol) in 
cyclohexane (90 ml) was photolyzed (circular battery of 
low-pressure mercury lamps,84% emission at 2537 ~, 
Rayonet photochemical chamber) for 6 h, after which time 
the azide absorptions in the infrared spe ctrum had 
disappeared. Some oxazolidinone (800 mg) had 
. 
crystallized out at the end of the reaction and was 
collected. The filtrate was evaporated and the semi-
crystalline residue was triturated with cyclohexane 
(25 ml) and filtered. The oxazolidinone was collected 
(2.9 g, total yield 65 %) and had m.p.127-130° (lit. 65 
0 130-133.5 , yield 43 %, by using more dilute solutions ) 
(Found: C, 68.3; H, 8.0; N, 7.1. Cale. for 
c11H15No 2 : C, 68.4; H, 7.8; 
(NH str), 1760, 1730 (C=O). 
N, 7.3 %). v 3360 
max 
P • m. r. o ( CDC 1 3 ) 1 . 3 - 2 . 5 
(m, 13H), 3.67 (m, lH, H vicinal to NH ), 5.67 (NH ) . 
2-Amino-l-hydroxytricycloJ 3.3.l.1 3 ' 7 Jdecc1ne 
(2-aminoadamantan-1-ol)hydrochloride (2.68) 
The oxazolidinone (2.66) was hydrolysed with 
2N hydrochloric acid as described by Curran and 
120. 
. 65 d . . Angier, an gave a 71% yield of 2-aminoadamantan-1-ol 
h d hl ·d (2 68) 310-360° (1· 65 y roe ori e . , m.p. it. no m.p. 
recorded) (Found: C, 58.5; H, 9.1; N, 6.8; Cl, 17.3. 
Cale. for c10H18 ClNO: C, 59.0; H, 8.9; N, 6.9; 
Cl, 1 7 . 4 % ) • V 3234, 1610, 1540. 
max 
P.m.r. 
o((co3 ) 2 so) 1.23-2.37 (m, 13H), 3.03 (m, lH vicinal to 
+ + NH 3 ) , 4 . 2 0 (OH) , 8 . 13 ( NH J ) . 
l-Hydroxytricyclo[3.3.l.1 317 ]decan-2-yl(N-toluene-p-
sulphonyl)amine (1-hydroxyadamantan-2-yl(N-toluene-p-
sulphonyl) amine) ( 2. 6 9) 
The hydrochloride (2.68) (100 mg, 0.49 mmol) was 
dissolved in dry pyridine (5 ml) with warming, and 
toluene-p-sulphonyl chloride (380 mg, 2 mmol) was added 
to the solution. After 3 days at o0 the mixture was 
. 
poured into ice-cold water and the crystalline solid 
that separated was collected, washed with water and dried. 
The toluene-p-sulphonyl derivative (105 mg, 67%) was 
0 
recrystallized from ether/light petroleum, b.p. 40-60 
0 
and had m.p. 160-161.5 (Found: C, 63.7; H, 6.8; 
N, 4.3; S, 9.7. 
N, 4.4; S, 10.0%). v 3550 (OH str), 3380 (NH str). 
max 
P.m.r. 6(CDC1 3 ) 1.2-2.2 (m, 13H), 2.40 (s, toluene CH 3 ), 
3.13 (d, J 7, lH vicinal to NH), 7.23, 7.33, 7.72, 7.85 
(aromatic H's)·. 
121. 
2-Hydroxytricyclo [3. 3 .1 . 1 .\ ' 7 ] deca~e (adamantan-2-ol) (2. 72) 
(a) Adamantan-2-one (10 g, 65 mmol) in methanol 
(200 ml) was treated with sodium borohydride (2.75 g, 
290 mmol) in portions over a period of 1 h, while 
maintaining the reaction temperature at 10°. The solvent 
was evaporated and the residue partitioned between ether 
and 20% aqueous potassium hydrogen carbonate. The 
ethereal layer was separated and dried (Na 2so4 ). 
Evaporation of the solvent afforded the alcohol (9.87 g, 
97%) m.p.* 299-300° (lit. 130 296.2-297.7°) V 3250 
max 
(OH str). P.m.r. c5(CDC1 3 ) 1.35-2.32 (m, 14H), 
1 . 6 3 ( s, lH, OH) , 4 . 18 ( m, lH, H 2) . 
(b) Adamantan-2-ol was also prepared by the reduction 
of adamantan-2-one with lithium aluminium hydride accord-
ing to the method of Schleyer and Nicholas130 (91%). 
Tricyclo[3.3~1.1 3 ' 7 Jdec-2-yloxycarbonyl chloride 
(adamantan-2-yloxycarbonyl chloride) (2. 73) 
The oxycarbonyl chloride (2.73) was prepared in the 
same way as adamantan-1-yloxycarbonyl chloride (2.63) in 
a yield of 68%, and had m.p. 43-45° after recrystalliz-
ation from petroleum ether (b.p. 40-60°) (Found: C, 61.5; 
H, 6.9; 
H, 7.0; 
Cl, 16.5. 
Cl, 16.5%). 
796, 765, 690 (C-Cl). 
Cale. for c 11H15o2c1 1 : C, 61.5; 
v 1775 (C=O), 1176 (C-0 str), 
max 
P.m.r. c5(CDC1 3 ) 1.60-2.33 
( m, 14 H) , 5 . 0 7 ( m, lH , H 2) . 
I' 
j· 
'I 
3 7 · Tricyclo[3.3.l.l ' ]dec-2 - yloxycarbonyl hydrazide 
(adamantan-2-yloxycarbonyl hydrazide) ( 2. 74) 
The oxycarbonyl hydrazide (2.74) was prepared by 
the method described previously (see adamantan-1-
yloxycarbonyl hydrazide) in 90% yield. After recry-
stallization from ether-cyclohexane the product had 
0 . 66 0 
m. p. 6 7 -6 8 (lit. 6 9- 7 0 ) (Found: C, 6 2 . 7 ; H, 8 . 6; 
N, 13.3. 
N, 13.3%). v 3312 (NH str), 1695 (C=O). 
max P.m.r. 
cS (CDC1 3 ) 1.37-2.25 (m, 14H), 3.73 (br m, 2H, NH2 ), 
4.90 (br m, lH H2), 6.22 (br m, lH, N H ). 
Tricyclo[3.3.l.1 3 ' 7 Jdec-2-yloxycarbonyl azide 
(adamantan-2-yloxycarbonyl azide) (2. 75) 
122. 
The oxycarbonyl azide (2.75) was prepared from the 
hydrazide (2.74) according to the method of Greidanus 66 
in a yield of 88%, and melted at 52-52.5° (d) (lit. 66 
0 52-54 ) after recrystallization from ethyl acetate 
0 
· (at -18 ) (Found: C, 6 0 . 1; H, 6 . 9 ; N, 19 . 2 . Cale. 
2210, 2190 and 2150 (N 3), 1720 (C=O). 
1.37-2.13 (m, 14H), 6.63 (m, lH, H2). 
\) 
max 
P • m. r . cS ( CDC 1 3 ) 
4-0xa-2-azatetracyclo[6.3.l.1 6 ' 10 .o1 ' 5 Jtridecan-3-one 
(adamantano [l,2-d ]oxazolidin-2-one) (2. 76) 
(a) Adamantan-1-yloxycarbonyl azide (6 g, 27 mmol) 
in cyclohexane was photolyzed for 15 h. The solvent 
was evaporated and the residue triturated with cold 
n -hexane. The solid was collected and recrystallized 
123 . 
.. 
from ethyl acetate to affcrd the oxazolidinone (1.09 g , 
21%) m.p. 131-133° (lit. 66 135-136°) v 3320 (NH str), 
max 
176 0 and 1730 ( C=O) . P.m.r. c5 (CDC1 3 ) 1.45-2.30 (m, 12H), 
2.45 (m, lH, H3), 4.20 (d, J 3, lH, H2), 5.38 (m, lH, NH). 
The residue from the evaporation of the filtrate 
was chromatographed on an alumina column. Elution with 
benzene-n-hexane (1:1) afforded adamantan-2-ylcyclohexyl 
0 
carbamate (2. 77) (2. 3 g, 31 %) m. p. 115-117 (Found: 
C, 7 3. 5; H, 9. 2; N, 4 . 9. Cale. for Cl7H27N02: 
C, 7 3 . 6; H, 9. 8; N, 5 .1 % ) \) 3330 (NH str) , 1680 
max 
( C=O) . P.m.r. c5 ( CDCl 3 ) 1.48-2.33 ( m, 2 4H) , 3.52 
(m' lH, NH) , 4.60 (m' lH, Hl') , 6.57 (m' lH, H2) . 
(b) The oxycarbonyl azide (2.75) (500 mg, 2.3 mmol) 
in dichloromethane (10 ml) solution was irradiated as 
in (a) . Evaporation of the solvent afforded a brown 
oil which was purified by chromatography on an alumina 
column. Elution with ether followed by benzene-ethanol 
(9/1) gave the oxazolidinone (25 mg, 9 %) , identical with 
that described in (a), and an intractable tar. 
l-Amino-2-hydroxytricyclo[3.3.l.1 3 ' 7 Jdecane 
(1-aminoadamantan-2-ol)hydrochloride (2.78) 
(a) The oxazolidinone (2.76) (1 g, 5.2 mmol) was 
added to 2N hydrochloric acid (100 ml) and the mixture 
heated on a steam bath for 2 h. The cooled solution was 
filtered and the filtrate evaporated to dryness to afford 
the hydrochloride (0.69 g, 65 %) m.p. 305-306° identical 
with the product described in (b). 
(b) 2-0xoadamantan-l- y lamjne (165 mg, 1 mmol) in ether 
(25 ml) was reduced with lithium aluminium hydride (150 mg, 
3.9 rnmol). l\fter stirring for 8 h at room temperature 
saturated aqueous sodium carbonate was added. The mixture 
was extracted with chloroform and the dried (Na 2so 4) 
extracts evaporated to. afford the amino-alcohol ( 159 mg, 
95%) m.p.* 271-273°. 
3 . 4 8 ( m, lH , H 2) . 
P.m.r. 6(CDCl 3 ) 1.17-2.33 (m, 13Il), 
The hydrochloride had m.p. 305-306° 
after recrystallization from ethanol-ether (Found: N, 6.7; 
Cl, 17.8. c10H18 NOC1 requires N, 6.9; Cl, 17.4%) 
v 3660-2380 (OH, NH + and CH str), 1990 (NH 3+). max 3 
Preparation of adamantano[l,2-d]oxazolidin-2-one (2.76) 
from l-aminoadamantan-2-ol (2.78) 
The amino-alcohol (70 mg , 0.42 mmol) was suspended 
in water (1 ml) and the mixture treated with phosgene in 
toluene (20 %, 0.5 ml, 2.4 mmol) and 2N sodium hydroxide 
0 (0.84 ml, 4.8 mmol) at 5 . The additions were carried 
out simultaneously, ensuring that the mixture remained 
alkaline. The mixture was stirred in the cold for 12 h 
after which time the additions were repeated and stirring 
continued for a further 6 h. The mixture was partit-
ioned between chloroform and lN hydrochloric acid. The 
chloroform layer was separated and the aqueous part 
extracted with chloroform. The combined extracts were 
dried (Na 2so4 ) and evaporated to afford a white 
crystalline solid (55 mg, 68%). Recrystallization from 
ethyl acetate afforded a compound with m. p . 132-134° 
· 66 ° h · · f d ·d t· 1 (lit. 135-136) and aving an in rare spectrum i en ica 
with that of adamantano[l,2-d]oxazolidin-2-one (2.76). 
l 
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SAXITOXIN ANALOGUES 
1) Introduction 
Saxitoxin (1.1) has a reduced purine skeleton, 
the N-3 and C-4 positions of which are linked by a 
three carbon bridge bearing an hydrated ketone at 
C-12 . A carbamoyloxy side chain is present at C-6, 
and is cis with respect to H-5, the reduced imidazole 
and pyrimidine rings are also cis fused. 
52 53 Armarego and Reece and Wegner and Rapoport 
have investigated the preparation of 2,8-diiminoper-
hydropurines, and the former demonstrated that the 
guanidinium groups play an important part in the 
activity of these analogues and of saxitoxin. Schantz 
54 
and coworkers have prepared a saxitoxin derivative 
in which the carbamyl group at 0-17 is absent, but 
which retains biological activity comparable to that 
. 
of saxitoxin. On the other hand, replacement of. the 
hydrated carbonyl group at C-12 with a methylene group 
by catalytic reduction of saxitoxin affords nontoxic 
d 'h d . . 55 d' · 11 lO . . h i y rosaxitoxin. Accor ing to Hi e it is t e 
guanidinium moiety around C-8 of saxitoxin which ·enters 
the sodium channel, while the guanidinium group around 
C-2 remains in the 'antechamber' of the pore. From 
the observations described above it may be concluded 
that the guanidinium groups (particularly around C-8) 
126. 
and the hydrated keton L' at C-12 are essential for 
saxitoxin-like biological activity, while the carbamyl 
part of the C-6 substituent is dispensable. 
these requirements, it was planned to prepare 
Based on 
2,8-dioxo- and 2,8-diiminoperhydropurines (3.1) and 
(3.2) with a three carbon chain between N-3 and C-4 
bearing a polar group at C-12. 
'In order to prepare 4-substituted 2,8-dioxoper-
hydropurines it was planned to introduce a nitromethyl 
side-chain at the 4-position of 5-substituted 
4-aminoimidazol-2(3H)-ones by fusion of the enamine 
with nitroacetic acid. Cyclization of the thus 
formed trisubstituted imidazolin-2-one was expected to 
afford 4-nitromethyl-2,8-dioxoperhydropurine, the 
nitromethyl group of which could be elaborated and 
cyclized to give a 2,8-dioxoperhydropurine (3.1) with 
a three carbon bridge between C-4 and N-3 and a polar 
group at C-12. The 2,8-diiminoperhydropurines were 
to be prepared similarly, or by conversion of the 
. 
dioxo compounds directly into the diimino deriva~ives. 
The following sections describe attempts to add 
the elements of nitromethane across the enamine-like 
part of 5-substituted-4-aminoimidazol-2(3H)-ones and 
l-substituted-2-aminocyclopent-l-enes. The cyclo-
pentane derivatives were required for the preparation 
of 3a-substituted-4,6-diaza-5-oxo- and 5-iminoper-
hydroindenes (3.3) and (3.4) which were to be compared 
with their heterocyclic analogues, the 4-substituted-
2,8-dioxoperhydropurines (3.1) and (3.2). This 
5 
4 
H 
N 
:)=x 
N 
H 
R 
(3 . 1) X=O, R=polar group 
(e.g. hydrated ketone) 
(3.2) X=NH, R=polar group 
(e.g. hydrated ketone) 
(3.3) X=O, R=polar group 
(e.g. hydrated ketone) 
(3.4) X=NH, R=polar group 
(e.g. hydrated ketone) 
( 3 • 5) 
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comparison should give a n indic a tion of the i mportance 
of the guanidinium group around C-8 in th e 2,8-diimino-
perhydropurine analogue (3.2) and in saxitoxin itself. 
Attempts were also made to prepare ethyl 2-amino-
5 , 6,7-trihydroindene-4-carboxylate (3.5) in order to 
study its catalytic reduction, and will b e describe d 
in the final section . 
2) Preparation of 4-aminoimidazol-2(3 ll )-oncs 
and their fusion with nitroacetic acid 
i) Discussion 
131 In 1969, Armarego succeeded in adding the 
elements of nitromethane across the a , B-double bond 
of enamines and enamides by fusing them with nitro-
acetic acid. Later, he prepared 8a-nitromethyl-cis -
octahydroquinazolin-2(1H)-one by fusing 3,4,5,6,7,8-
hexahydroquinazolin-2(1H)-one with nitroacetic acid~ 32 
It wa s hoped that the same methods could be used to 
add the elements of nitromethane across the 4,5-double 
bond of 5-substituted-4-aminoimidazol-2(3H)-ones. The 
adducts were then to be converted by a s e ries of 
reactions into perhydropurines (3.1) and (3.2). 
Initial efforts were directed toward the s ynthe s i s 
of 4-amino-5-ethoxycarbonylimidazol-2(3 H)-one (3.10). 
The compound was to have been prepared according to 
the sequence of reactions illustrated in Scheme 3.1 . 
Ethyl a -oximinocyanoacetate (3 . 7) was p r e pare d by 
nitrosation of ethyl cyanoacetate (3.6) accord i ngto an 
adaptation of the procedure us e d by Fe rri s and 
SCHEME 3.1 
C.02C2 H 5 
.._ C==N·OH 
( 3 • 6) 
co2c2H5 
CH-NHCONH2 
I 
CN 
( 3 • 9) 
0 
I 
CN 
( 3 . 7) 
(3.11) 
129. 
102C2H5 
---IP-"~ CH-NH; 
I e 
CN C7H7S03 
H 
N 
N 
H 
( 3 • 8) 
(3.10) 
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coworkers for the n i trosation of malononitril e . 
The oximino compound was reduced with aluminium amalgam 
and water essentially by the method of Robinson and 
Shaw134 , to afford ethyl a-amino a -cyanoace tatewhich was 
isolated as the toluene-p -sulphonate (3.8). The free 
. 
amine polymerizes readily at room temperature. The 
amine toluene-p -sulphonate (3.8) and the free amine 
both failed to afford the imidazol-2(3H)-one (3.10) 
when treated with urea. The free amine polymerized 
when heated with urea in ethanol, while the amine 
toluene-p-sulphonate did not react with urea under a 
variety of conditions. When potassium isocyanate and 
the toluene-p-sulphonate (3.8) were heated in water, a 
high yield of ethyl a -urcido a -cyanoacctatc (3.9) was 
obtained. The same compound (3 . 9) was prepared from 
the free amine and potassium isocyanate in acetic acid 
according to the method of Cook and Hunter. 135 
However, the melting point recorded by Cook and Hunter 
appears to be incorrect (see Experimental). 
The ureido compound (3.9), on heating in concentr-
ated hydrochloric acid,afforded hydantoin (3.11) which 
probably arises from the hydrolysis and decarboxylation 
of the imidazol-2(3H)-one (3.10). When the ureido 
compound (3.9) in ethanol was treated with sodium 
ethoxide, a yellow precipitate was formed. Micro-
analyses indicated it to be a sodium salt although 
consistent analytical results could not be obtained 
for separate preparations. 135 Cook and Hunter found 
that ureas of the type (3.12) were converted into the 
corresponding oxuzolcs (3.13) with sodium cthoxid . 
Acidification of the sodium salt described above 
however, afforded a complex mixture of products 
which could not be adequately separated. Treatment 
of the ureido compound (3.9) with ethanolic hydrogen 
chloride afforded an extremely hygroscopic oil. The 
product hydrolysed rapidly and was converted into 
131. 
hydantoin in solution. The precipitation of ammonium 
chloride from the reaction mixture could often be 
observed, especially when the solution was exposed to 
atmospheric moisture. Attempted picratization of the 
product was unsuccessful and it was not characterized. 
Treatment of the ureido compound (3.9) with aqueous 
potassium hydroxide resulted in the formation of a small 
quantity of a potassium salt, the remainder of the 
product being starting material. . h d 136 Smit an Yates 
however, were able to prepare 4-amino-5-carboxamido-
imidazol-2(3H)-one (3.15) from a-ureido a-cyanoacetamide 
(3.14) with aqueous sodium hydroxide (5 %) (see Scheme 3.2). 
The ureido compound (3.14) was prepa~ed from ethyl 
a-ureido a-cyanoacetate (3.9) and liquid ammonia. 
4-Amino-5-carboxamidoimidazol-2(3H)-one (3.15) appeared 
to be a suitable compound for the study of 
enamine - nitroacetic acid fusion reactions, but other 
enamines were prepared for a comparative study. 
4-Aminoimidazol-2(3H)-one (3.16) was prepared by 
heating equimolar quantities of aminoacetonitrile 
hydrogen sulphate and potassium isocyanate in water 
(3.12) 
co2c2H5 
rH·NHCONH2 
CN 
( 3 • 9) 
(3.13) 
R = a -naphthyl 
CONH2 
~ 1HNHCONH2 
H 
N>==O 
N 
H 
(3.15) 
Scheme 3.2 
CN 
(J.14) 
132. 
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on a steam bath. 'l'he compound was hydrolysed to 
hydantoin on heating in concentrated hydrochloric acid. 
137 Cook and coworkers prepared 5-amino-2-methyl-
amino-4-ethoxycarbonylthiazole (3.17) from ethyl 
a -aminocyanoacetate and methyl isothiocyanate. When 
. 
the thiazole was heated in refluxing aqueous sodium 
carbonate, the isomeric 5-amino-2-mercapto-4-ethoxy-
carbonyl-l-methylimidazole (3.18) was obtained. We 
prepared the imidazole (3.18) in the same way, but 
found the thiazole (3.17) to contain approximately 
15 % of the imidazole. 
4-Methyl-5-ethoxycarbonylimidazol-2(3H)-one (3.19) 
and 4-ethoxycarbonylimidazol-2(3H)-one (3.20) were 
d b k th d 143,144 f f . 'th prepare , y nown me o s, or usion wi 
nitroacetic aoid. These compounds are 'enamides' but 
do not possess the 'enamine' structure of the 4-amino-
imidazol-2(3H)-ones, and may prove useful in 
elucidating the mechanism of the addition of the 
elements of nitromethane to the 4-aminoimidazol-2(3H)-
ones. 
Each of the compounds described above was fused 
with nitroacetic acid. The fusions were carried out 
by thoroughly mixing the compound with two equivalents 
of nitroacetic acid. Often the decomposition of· the 
acid with liberation of carbon dioxide occurred at 
room temperature, while in other cases elevated 
temperatures were necessary. The fusions were repeated 
before the product was isolated by evaporation of 
nitromethane formed in the reaction. The p.m.r. spectra 
C2H5o2c 
H 
N 
N 
H 
(3.16) 
H 
N)=o 
N 
H 
(3.20) 
134. 
N 
>-NHCH3 
s 
(3.17) 
~sH 
(3.18) 
H 
c2H5o2c N)=o 
H3C N H 
(3.19) 
13 S . 
of the crude residues we r e measured before work up. 
The protons of the nitromethyl group of the fusion 
products should resonate in the region of c5 4. 60 pµn, 132 
and provide an indication of the extent of reaction. 
Fusion of 4-aminoimidazol-2(3H)-one (3.16) with 
nitroacetic acid failed to yield a nitromethane adduct. 
a-Ureidoacetamide (3.21) was isolated in high 
yields and was identified by comparison with an authentic 
1 d f h 1 ·a 138 samp e prepare rom et y a-urei oacetate by the 
h d f ·1 139 h d bbl met o o Bai ey. Te pro uct pro a y comes about 
through hydrolytic ring opening of the imidazol-2(3H)-one 
(3.16) with traces of water under the strongly acidic 
52 
reaction conditions. Armarego and Reece have reported 
a similar 5-membered ring opening reaction in their 
attempts to introduce a nitromethyl group at the C-4 
position of hexahydropurines. On the other hand, the 
fusion of 4-amino-5-amidoimidazol-2(3H)-one (3.15) with 
nitroacetic acid afforded a small proportion of starting 
material with a larger quantity of 4-amidohydantoin 
. (3.22) _ 140 The hydrolytic reactions d e scribed above 
came about when traces of water were present in the 
reaction mixture. The rigorous exclusion of water from 
the mixture prevented any reaction from taking place. 
Unfortunately, nitromethane adducts were not detected 
in the reaction products. 
5-Amino-2-methylamino-4-ethoxycarbonylthiazole 
(3.17), 5-amino-2-mercapto-4-ethoxycarbonyl-l-methyl-
imidazole (3.18), 4-methyl-5-ethoxycarbonylimidazol-
2(3H)-one (3.19) and 4-ethoxycarbonylimidazol-2(3H) -one 
136 . 
H NHCONH2 
N )==o ..... CH2 I H2N N CONH2 H 
(3.16) ( 3 . 2 1) 
H H H2NOC N>==O H2NOC N>==O ... 
0 N H2N N H H 
(3.15) (3 . 22) 
(3.20) all failed to re ~ct with nitroacetic acid and 
the starting materials were recovered unchanged. 
Attempts to introduce a nitromethyl group into 
the 4-position of 4-aminoimidazol-2(3H)-ones were 
abandoned because of the lack of reactivity of these 
compounds toward nitroacetic acid. 
l J ·;. 
1,3-Diguanidinopropane was prepared for comparison 
with saxitoxin because both contain guanidinium groups 
separated by three carbon atoms. 
ii) P.m.r. Spectra 
The p.m.r. spectrum of 4-arninoimidazol-2(3H)-one 
(Fig. 3-1) indicates that the compound exists predomin-
antly, if not entirely in the imino form rather than the 
* enamine form (3.16) The protons at C-5 appear as a 
doublet (J 5 Hz) probably because of coupling with the 
adjacent NH proton. The doublet collapses to a 
singlet with deuterium oxide. The NH proton H-1 appears 
as a broad triplet (J 5 Hz), while the Nll protons H-2 and 
H-4' appear as a broad singlet. The protons H-1, H-2, 
and H-4' all disappear on deuterium exchange. IIydantoin 
on the other hand ~xhibits no coupling for the C-5 
protons, although a chemical shift difference of approx-
imately 0.7 Hz can be observed, while the NH protons 
H-1 and H-3 appear as broad signals at o 8.03 and o 11.0 
respectively. It is of interest to compare the p.rn.r. 
* 4-Arninoimidazol-2(3 H)-one (3.16) would therefore be 
more correctly called 4-iminoimidazolidin-2-one, 
however, the former name will be retained for 
consistency. 
80 
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spectrum of a -ureidoacetamide (Fig. 3.2) with that 
of 4-aminoimidazol-2(3H)-one (Fig. 3.1). The 
acetamide also exhibits a doublet (J 6 Hz) for the 
methylene protons, while the NH proton adjacent to 
142. 
the methylene group appears as a broad triplet (J 6 Hz). 
The p.m.r. spectra of 5-amino-2-methylamino-4-
ethoxycarbonylthiazole (Fig. 3.3) and 5-amino-2-
mercapto-4-ethoxycarbonylimidazole (Fig. 3.4) indicate 
that both compounds exist in the enamine tautomeric 
forms. In the p.m.r. spectrum of the thiazole, the 
N-methyl group of the imidazole impurity can be 
observed at o 3 . 38. 
iii) Experimental 
Ethyl a -oximinocyanoacetate (3.7) 
Ethyl a-oximinocyanoacetate was prepared from 
ethyl cyanoacetate according to the method employed by 
. h d 133 f h · -f Ferris, Sane ez an Mancuso or t e preparation o_ 
oximinomalononitrile from malononitrrle. 
Ethyl cyanoacetate (21.5 g, 190 mrnol) was added 
to a mixture of water (10 ml) and acetic acid (50 ml). 
The solution was cooled to -10° and powdered sodium 
nitrite (25 g, 360 mmol) added over a period of 30- m. 
After the addition was complete the solution was stirred 
at less than 5° for 6 h. Ether (200 ml) was added and 
the mixture stored at -20° overnight. The mixture was 
filtered and the solids washed with ether (150 ml). 
j 
143. 
The filtrate was evaporatcc l to dryricss under r8duccd 
.pressure. The crystalline residue was suspended in water 
and collected by vacuum filtration. Recrystallization of 
the residue from water afforded the oxime (14.7 g, 55 %) 
melting at 135-137° (lit. 141 133°, 87 % yield from the 
addition of acetic acid to a solution of ethyl 
cyanoacetate and sodium nitrite). 
Ethyl a-aminocyanoacetate toluene-p-sulphonate (3.8) 
Ethyl a-aminocyanoacetate was prepared by reduction 
of the oxime (3.7) with aluminium amalgam by the method 
f b · d h 134 . h h d. f. . h h o Ro inson an Saw, wit t e mo i ication tat t e 
aluminium used in the preparation of the amalgam was 
activated by etching with dilute aqueous sodium hydroxide. 
The product was isolated as the toluene-p-sulphonate 
(61% yield) and had m.p. 119-121° (lit. 134 115-117°). 
The free amine was prepared by treating the toluene-
p -sulphonate with 2N sodium hydroxide and the solution 
extracted with chloroform. Evaporation ( <25°) of the 
dried extracts gave the amine as a yellow oil which was 
used immediately in subsequent reactions. 
Ethyl a-ureidocyanoacetate (3.9) 
(a) Ethyl a -aminocyanoacetate toluene-p -sulphonate 
(1.5 g, 5 mmol) was dissolved in hot water (35 ml) and a 
solution of potassium isocyanate (0.45 g, 5.5 mmol) in 
water (10 ml) added. The solution was heated to 75° on a 
steam bath and then allowed to cool in ice. The 
precipitate was collected and recrystallized from ethanol to 
afford the ureido compound (0.85 g, 95 %) melting at 193-194° 
(d) (lit. 135 166°). 
(b) 'rhc urcido compo11nd wc1s also prcpc1rcd by the 
method of Cook and Hunter135 in 75 % yield and had m.p. 
193-194° (d) (lit. 135 166°) (Found: C, 41.8; H, 5.2; 
Cale. for c 6H9N3o3 : C, 42.1; H, 5.3; 
144. 
N, 24.3. 
N, 24.6 %). v 3490, 33.50 (NII str), 1725 (ester C=O), 
max 
1670 (amide C=O), 1585, 1563 (NH bend). P.m.r. o((CD) 3SO) 
1. 5 5 ( t , 3H , CH 2 CH 3 ) , 4 . 18 ( q, 2 H , CH 2 CH 3 ) , 5 . 4 9 ( d, 
J 6.5, lH, H-a), 6.03 (br s, 2H, CONH 2 ), 7.12 (d, J 6.5, 
lH, NHCO) • 
When the ureido compound (171 mg, 1 mmol) was heated 
under reflux in concentrated hydrochloric acid (5 ml) a 
white solid precipitated from the solution on cooling. 
Recrystallization from ethanol afforded a crystalline 
solid (89 mg, 89%) melting at 218-219.5°, and having 
infrared and p.m.r. spectra identical with those of 
hydantoin (m.p. 222-224°). 
4-Arninoimidazol-2(3H)-one (3.16) 
Arninoacetonitrile hydrogen sulphate (15.4 g, 0.1 mnol) 
in water (100 ml) was treated with potassium isocyanate 
( 8 . 1 g , 0 . 1 mmo 1 ) . The mixture was heated on a steam 
bath for 1 h. Evaporation of the solution afforded a 
white solid which was dried &n vacuo before being 
extracted with ethylacetate in a soxhlet extractor for 12 h. 
During the extraction the product separated, and crystall-
ization continued on cooling. Recrystallization of the 
product from ethanol afforded the imidazolone (3.2 g, 32 %) 
0 
melting at 122-123 (Found: C, 36.0; H, 5.1; N, 41.9. 
v 3400 (NH str), 1660, 1620 (amide). 
max 
P.m.r. 
cS ( ( CD 3 ) 2 SO) 4 . 4 3 ( d , J 6 , 2 H , H - 5 ) , 6 . 3 8 ( b r s , 2 H , 
H-3 and H-4'), 7.03 (t, J 6, lH, H-1). 
145. 
The aminoimidazolone (200 mg, 2 mmol) was heated 
under reflux with concentrated hydrochloric acid (10 ml). 
Evaporation of the solution and recrystallization of the 
residue from ethanol afforded hydantoin, m.p. 221-223° 
(m.p. 222-224°) identical with an authentic sample. 
a-Ureidocyanoacetamide (3.14) 
Ethyl a-ureidocyanoacetate (200 mg, 1.17 mmol) was 
dissolved in ethanol (30 ml) and liquid ammonia (10 ml) 
added. After standing for several hours the solution 
was evaporated to dryness and the residue was 
recrystallized from ethanol to afford the amide as 
colourless needles (105 mg, 63%) m.p. 204-206° (lit. 136 
202-203° from a-oximinocyanoacetamide). 
4-Amino-5-carboxamido-imidazol-2(3H)-one (3.15) 
The imidazolone was prepared according to the method 
of Smith and Yates136 (76%) from a-ureidocyanoacetamide 
and 5% aqueous sodium hydroxide and had m.p. >360° 
(lit. 136 >370°). 
5-Amino-2-methylamino-4-ethoxycarbonylthiazole (3.17) 
The thiazole was prepared by the method of Cook, 
Downer and Heilbron137 in 80% yield by the condensation 
of ethyl a-aminocyanoacetate and methylisothiocyanate, 
146. 
m . p . 16 4 ° ( et h an o 1 ) ( 1 it . 1 1 7 16 2 °) . · .. v 3400, 3275, 
max 
3150 (NH str), 1650, 1600 (ester C=O, C=N). P.m.r. 8(CDC1 3 ) 
1.23 (t, 3H, CH 2cH 3), 2.80 (d, 3H, NCH 3), 3.20 (br s, 
0.25H, NCH 3 rearrangement product, see below), 4.23 (q, 
2H, CH 2 CH 3 ), 6.76 (br s, 3H, NH's). 
5-Amino-2-mercapto-4-ethoxycarbonyl-l-methyl imidazole (3.18) 
The imidazole was prepared by base catalyzed 
rearrangement of the above thiazole as described by Cook 
t Z 137 . e a . in a yield of 88 %, m.p. 212-213° (d) (lit.137 
211° (d)). v 3460, 3330, 3130 (NH and SH str), 1680 
max 
(ester),1645 (amide). P.m.r. 8(CDC1 3 ) 1.23 (t, 3H, CH 2 cH 3 ), 
3.36 (s, 3H, NCH 3), 4.23 (q, 2H, CH 2cH 3), 6.43 (br, 2H, 
NH 2 ) . 
4-Methyl-5-ethoxycarbonylimidazol-2(3H)-one (3.19) 
Ethyl a -oximino-acetoacetate was prepared in 89 % 
yield from ethyl acetoacetate according to the method of 
142 Adkins and Reeve. The oximino compound (4.77 g, 
30 mmol) was dissolved in ethanol (15 ml) and O.SN 
hydrochloric acid (60 ml) and the mixture shaken with 
10 % palladium-on-charcoal (200 mg) and hydrogen at 
5 atmospheres pressure. After 3 days, the mixture was 
filtered, and SN hydrochloric acid (3 ml) added to the 
filtrate, followed by potassium isocyanate (3.65 g, 
45 mmol) in water (14 ml). The solution was heated to 
65° and on cooling, the product precipitated. Recry-
stallization from water afforded the imidazol-2(3H)-one 
(1.06 g, 2l 'Yo ) melting at :~29-231° ·(lit . 1 '1 3 2i5-226°). 
v 1720 (ester C=O), 1700 (amide C=O). 
max P.m.r. 
o ( (CD 3 ) 2so) 1.08 (t, 3H, CH 2CH 3), 2.20 (s, 3H, CH 3), 
4.18 (q, 2H, CH 2CH 3), 10.20 (br s, lH, NH), 10.63 
(br s, lH, NH). 
4-Ethoxycarbonylimidazol-2(3H)-one (3.20) 
The ethoxycarbonylimidazolone was prepared by 
esterification of 4-carboxy-imidazol-2(3H)-one with 
ethanol and concentrated sulphuric acid according to 
the method of Hilbert. 144 
a-Ureidoacetamide (3.21) 
14 ~/. 
(a) Ethyl a -ureidoacetate (500 mg, 3.4 mmol) was 
dissolved in a minimum of ethanol and ammonia gas bubbled 
into the solution for l h. The solution was refrigerated 
for 2 days and the amide (186 mg, 61.6 %) was collected. 
0 . 139 0 It had m.p. 201-202 (eff.) (lit. 204 (eff.)) (Found: 
C, 30.8; H, 6. 1; N, 3 5. 8. Cale. for C3H7N302: 
3 0 . 8; 6 . 0 ; 35.9 %). ... , P.m.r: o ( (CD 3 ) 2so) C, H, N, 
3.62 ( d' J 6 ' 2H, CH 2 ) , 5.77 ( s' 2H, NHCONH2), 6.28 
( t' J 6 ' lH, NHCO) , 7.35 and 7.12 ( m' 2H, H 2NCO) . 
When ethyl a -ureidoacetate (500 mg, 3.4 mmol) in 
ethanolic ammonia (30 ml) was heated in a sealed tube at 
0 95 for 12 h, hydantoin was obtained in quantitative 
yield. 
(b) 4-Aminoimidazol-2(3H)-one (99 mg, 1 mmol) and 
nitroacetic acid (206 mg, 2 mmol) were stirred and warmed 
until effervescence began. The temperature was 
148. 
maintained at 35-45° unti J effervesce nce ceased . The 
excess of nitromethane was removed in vacuo, and the 
residue was fused with a further quantity of nitroacetic 
acid. After the removal of excess nitromethane, the 
residue was recrystallized from ethanol. It had m.p. 
198-200° (eff.) (lit. 13.9 204°) and infrared and p.m.r. 
spectra were identical with those described above. 
Hydantoin-4-carboxamide (3.22) 
4-~mino-5-carboxamidoimidazol-2(3li)-onc (142 mg, 
1 mmol) was fused with nitroacetic acid (203 mg, 2 rnmol) 
by the procedure described above (see a -ureidoace t-
amide (b) ) . The residue was triturated with ethanol and 
the solid collected. Recrystallization from e thanol 
afforded the hydantoin (100 mg, 70 %), m.p. 251-253° (eff.) 
( 1 it. 14 O 2 4 9 ° ( e ff. ) ) (Found: N, 2 8 . 0 . 
c4H5N3o3 0.5H 20: N, 27.6 %). 
1,3-Diguanidinopropane sulphate 
Cale. for 
. 
A mixture of 1,3-diaminopropane (3.7 g, 50 rnmol), 
s-methyl-isothiouronium sulphate and water (25 ml) was 
heated under reflux for 3 h. After standing at room 
temperature for 24 h the product was collected by vacuum 
0 filtration (4.1 g, 60 %) m.p. 321 (d) (Found: C, 23.·S; 
H, 6 . 2 ; N, 3 2 . 7; s' 12. 6. C5Hl6N6Sl04 requires: 
C, 2 3. 4; H, 6 . 3 ; N, 3 2. 8; s, 12 . 5 % ) . The dipicrate 
had m. p. 235° (Found: C, 33.2; H, 3 . 3 ; N, 2 7 . 2. 
Cl7H20Nl20l4 requires: C, 3 3 .1; H, 3 . 3 ; N, 27.3 %). 
3) Preparation of 2-aminocyclopcnt-1-e nes 
and their fusion with nitroacetic acid 
i) Discussion 
In an approach to the synthesis of Sa-substituted 
quinazolines with a reactive side-chain, Armarego and 
149. 
b h · 145 f d 2 . 1 Ko ayas i use -amino- -cthoxycarbonylcyclohcx-1-ene 
(3 . 23) with nitroacetic acid and obtained ethyl cis-2-
amino-trans-2-nitromethylcyclohexane-l-carboxylate (3.24). 
The adduct readily lost the elements of nitromethane on 
heating or on mild treatment with acid or base. 
We attempted the addition of the elements of 
nitromethane to the enamines; 2-amino-l-cyanocyclopent-
1-ene (3.25) and 2-amino-l-ethoxycarbonylcyclo-pent-1-ene 
(3.26) in an approach to the preparation of 
3a-substituted-4,6-diaza-5-oxoperhydroindenes and their 
5-imino analogues. 
h 146 1 · d h d 2 . 1 T orpe c aime to ave prepare -amino- -
cyanocyclopent-1-ene (3.25) in 84% yield by cyclizing 
adiponitrile in ethanol with a catalytic amount of sodium 
ethoxide. Our attempts to repeat Thorpe's preparation 
were unsuccessful, and no cyclization was detected even 
after extended reaction times. Catalytic amounts of 
potassium t -butoxide also failed to bring about c ycliz-
147 
ation. However, Thompson was able to prepare 
2-amino-1-cyanocyclopent-l-ene in 85% yield by treatment 
of adiponitrile with a molecular equivalent of sodium 
t-butoxide under heterogeneous conditions. Thompson 
prepared the heterogeneous mixture by the addition of 
mi.------------------------- -
150. 
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Fig. 3.5 The p.rn.r. spectrum of 2-arnino-l-cyanocyclopent-1-ene in (CD 3 ) 2so 
at 60 MHz. I--' 
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t -butanol to a suspension of sodium in toluene . 
However, we found potassium t -butoxide in toluene to 
be equally effective in facilitating the cyclization. 
d . 14 8 . f Hammer an Hines have presented in rared spectro -
scopic evidence to indicate that 2-amino-1-cyanocyclo-
. 
pent-1-ene (3.25) exists predominantly as the enamine 
(3.25) rather than the imine (3.27). The infrared 
152. 
spectrum of the enamine exhibits a conjugated nitrile 
-1 
absorption at 2180 cm , and NH 2 stretching and bending 
-1 
vibrations at 3440, 3360, 3250 and 1650 cm respectiv ely. 
The p.m.r. spectrum (Fig. 3.5) provided further evidence 
for the enamine structure, and exhibits a broad two 
proton singlet representing the amine protons. The 
methylene protons H-3 and H-5 appear as a triplet 
representing four protons, while the methylene protons 
H-4 appear as a two proton quartet . 
2-Amino-l-ethoxycarbonylcyclopent-1-ene (3.26) 
was db h h d f . k 149 prepare y t e met o o Diec mann. Its 
p.m.r. spectrum (Fig. 3.6) indicates that the compound 
exists in the enamine tautomeric form. 
2-( N-Acetyl )amino-l-cyanocyc lopent-l-ene (3.28) was 
prepared by heating the enamine (3.26) in refluxing 
acetic anhydride. 
The three enamines (3.25, 3.26 and 3.28) were 
each fused with nitroacetic acid as for enamines 
described in Section 2) . When 2-amino-1-cyanocyclo-
pent-1-ene (3.26) was fused with nitroacetic acid, a 
brown oil was obtained which, from its infrared spectrum, 
C2H502C 5 
3 
NH2 
4 
CH2 C ur b O C y C l i C 
protons 
CH3 
I' I I' I'~ If I I I I I I I I I I If I' I I 
6.0 5.0 p M (O) 4.0 3 .0 2.0 1.0 
rig. 3.6 The p.rn.r. spectrum of 2-arnino-l-ethoxycarbonylcyclopent-1-ene 
in CDC1 3 at 60 MHz. f--J 
Vl 
w 
~ 
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appeared to be a mixture o f the starting material and 
-1 2-cyanocyclopentanone (3.29) (ketone absorption 1760 cm 
( l l. t. 14 8 17 5 5 . cm- l) and · d · · 1 2 2 4 - l unconJugate nitri e 3 cm 
( 1 it . 14 8 2 2 5 0 cm - l ) ) . No addition products could be 
detected by p.m.r. spectroscopy. With nitroacetic acid, 
the acetate (3.28) afforded a high yield of 
2-(N-acetyl)amino-l-amidocyclopent-l-ene (3.30), again 
no addition products were observed. 
In our hands, ethyl cis-2-amino-trans-2-nitromethyl-
cyclohexanecarboxylate (3.24) could be prepared from 
2-amino-1-ethoxycarbonylcyclohex-l-ene (3.23) by fusion 
of the latter with nitroacetic acid according to the 
h d f d b h . 145 met o o Armarego an Ko ayas i. Under the same 
conditions however, 2-amino-l-ethoxycarbonylcyclopent-
1-ene (3.25) failed to afford a nitromethane adduct with 
nitroacetic acid. Hydrolysis appears to have been the 
only reaction, no reaction was detected under dry 
reaction conditions. The failure of the fusion 
-reactions of the cyclopentenamines may have been due to 
. 
the instability of the five-membered nitromethane a9ducts. 
Ethyl 2-cyano-2-hydroxycyclopentane carboxylate is known 
to dehydrate readily to yield ethyl 2-cyanocyclopent-1-ene 
carboxylate150 while l-acetoxy-1,2-dicyanocyclopentane 
eliminates acetic acid readily to afford l,2-dicyanb-
151 
cyclopent-1-ene, and serve to demonstrate the 
instability of this class of compounds. 
Armarego and Milloy152 have studied the reduction 
of quinazolinecarboxylic acids which were prepared from 
---
C02R 
N 
NAO 
H 
(3.31) 
Scheme 3.3 
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2-oxocyclohcxylylyoxylic 1cid cJ11u· u.rc«:1. Tlrcy founc.1 Lh ttt 
when methyl 1,2,5,6,7,8-hexahydro-2-oxoquinazoline-4-
carboxylate (3.31, R=CH 3 ) was reduced catalytically, a 
mixture of the ester (3.32, R=CH 3 ) and its 8a-H tautomer 
(3.33, R=CH 3 ) was obtained (see Scheme 3-3). The ester 
was rapidly converte~ into the 8a-H tautomer in acid 
solution. Reduction of the corresponding acid (3.31, 
R=H) gave only the 8a-H tautomer (3.33, R=H). We 
attempted to extend this study to the cyclopentyl analogues 
(3.37) and to investigate their fusion reactions with 
nitroacetic acid. The proposed reaction sequence is 
illustrated in Scheme 3-4. Ethyl 2-oxocyclopentyl 
glyoxylate (3.34) was prepared in high yield by an 
153 
adaptation of the method of Snyder and coworkers for 
the preparation of ethyl 2-oxocyclohexylglyoxylate. The 
p.m.r. spectrum of ethyl 2-oxocyclopentylglyoxylate is 
illustrated in Figure 3.6, and indicates that the 
compound exists primarily in the enol tautomeric form. 
All attempts to hydrolyse the ester (3.34) to the 
acid (3.35) were unsuccessful. Under mild conditions 
(e . g . dilute sulphuric acid, dilute potassium hydroxide, 
or chloroform-lN sulphuric acid-silica gel) the ester 
was unchanged, while in refluxing dilute sulphuric acid, 
cyclopentanone was detected indicating that the ester 
(3.34) had hydrolysed and decomposed. 
Reaction of the ester (3.34) with urea in the 
presence of acid afforded complex mixtures of products 
from which the desired cyclopentapyrimidinone (3.36) 
could not be isolated, while under neutral conditions, 
no reaction was detected. 
--
COC02C2H5 
0 
( 3 . 34) 
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NH 
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H 
(3. 37) 
~ 
Scheme 3.4 
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(3.35 ) 
C02H 
N 
N~O 
H 
(3. 36) 
f--' 
lll 
-..J 
. 
~ 
OH 3 
4 
5 
13 .0 12. 0 
0 
c-co2cH2CH3 I OH 
CH2 
Car b O Cy Cl i C 
protons 
8 0 7.0 6.0 5.0 PPM ( ~ l 4.0 3.0 2.0 
Fig. 3.7 The p.m . r . spectrum of ethyl 2-oxocyclopentyl g l yoxalate in 
CDC1 3 at 60 MHz . 
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160. 
When treated with hydrazine in aqueous e thanol 
(~30% ) the ester (3.34) afforded ethyl 4,5-trimethylene-
pyrazole-3-carboxylate (3.38) (57%) and 5,6-trimethylene-
4-oxypyridazin-3-one (3.39) (29%). Elguero and 
154 
coworkers have prepared the pyrazole (3.38) in 62 % 
yield from the ester ·( 3. 3 8) with hydrazine in aqueous 
ethanol. They claim that the pyrazole precipitates from 
the cool reaction mixture. However, we found the 
pyridazin-3-one (3 . 39) to be less soluble in ethanol 
and more soluble in water than the pyrazole (3.38). 
Therefore, when the reaction was conducted in absolute 
to 75% aqueous ethanol, the pyridazin-3-one precipitated 
from the reaction mixture, whereas, when 25% aqueous 
ethanol was used the pyrazole was precipitated. 
Both the pyrazole (3.38) and the pyridazin-3-one 
(3.39) failed to afford a nitromethane adduct with 
·nitroacetic acid. Because of the inability of the 
enamines to form stable nitromethane adducts attempts 
.to prepare 3a-nitromethyl-4,6-diaza-5-oxoperhydroindenes 
and their 5-imino analogues were abandoned. 
ii) Experimental 
2-Arnino-l-cyanocyclopent-1-ene (3.25) 
Adiponitrile (10.8 g, 0.1 rnrnol) was added dropwise 
to a vigorously stirred suspension of potassium 
t-butoxide (11.3 g, 0.1 rnrnol) in benzene (120 ml). The 
mixture was heated under reflux for 2 hand allowed to 
stand overnight at room temperature. Water (SO ml) was 
added slowly and the organic solids were collected by 
lGl . 
.. 
vacuum filtration. The benzene phase was washed with 
water (50 ml) and more crystals separated. The aqueous 
phases were extracted with chloroform and the combined 
organic phases washed with water (50 ml), dried and 
evaporated to dryness. Recrystallization of the 
crystalline products and residue afforded 2-amino-1-
cyanocyclopent-l-ene (84 g, 78%), m.p. 148-149° (lit. 147 
147-148°). \J 3440, 3360, 3250 (NH str), 2180 (nitrile), 
max 
1650 (NH bend) . P.m.r. cS(CDC 1 3 ) 1. 80 (m, 2H, H-4), 
2.33 (m, 4H, H-3, H-5), 6.30 (br s, 2H, NH 2 ). 
2-Arnino-1-ethoxycarbonylcyclopent-l-ene (3.26) 
This was prepared from ethyl 2-oxocyclopentane-
155 
carboxylate and ethanolic ammonia according to the 
method of Dieckmann, 149 m.p. 57-59° (lit. 149 60°). 
3460, 3350 (NH str), 1737 (ester), 1670 (NH bend). 
\) 
max 
P.m.r. cS(CDC1 3 ) 1.25 (t, 3H, -OCH 2c H3 ), 1.83 (m, 2H, H-4), 
2 . 4 7 ( m, 4 H , H - 3 , H- 5) , 4 . 1 7 ( q, 2 H, -OCH 2 CH 3 ) , 
5·.82 (br s, 2H, NH 2 ). 
2-( N-Acetyl)amino-l-cyanocyclopent-l-ene (3.28) 
2-Arnino-l-cyanocyclopent-1-ene (432 mg, 4 mmol) was 
heated in gently refluxing acetic anhydride (6 ml) for 
45 min. and then cooled in ice. After standing in the 
cold for 12 h the crystals were collected and recryst-
allized from ether to afford the acetate (335 mg, 56 %), 
0 
m. p. 13 0-13 2 (Found: C, 6 4 . 5 ; H, 6 . 8 ; N, 18 . 7 . 
.. 
\J 3290, 3220, 3130 (NH str), 2195 (nitril e ), 1720 
max 
(acetate C=O). P.rn.r. o(CDC1 3 ) 1. 77-3.4 (m's, 6H, 
methylene protons), 2.13 (s, 3H, acetyl CH 3), 
8.53 (br, lH, NH). 
. 
2-(N-Acetyl)amino-l-carboxamidocyclopent-l-ene (3.30) 
162 . 
The acetate (3.28) (75 mg, 0.5 mmol) was fused with 
nitroacetic acid (1.03 mg, 1 mmol) at 45°. After the 
evolution of carbon dioxide had ceased, the excess of 
nitromethane was evaporated in vacuo . The fusion was 
repeated and the crystalline residue dissolved in benzene. 
The benzene solution was filtered and the filtrate 
evaporated to afford the amide (80 mg, 95%), m.p. 195-196° 
( Found : C, 5 7 . 2 ; H , 7 . 3 ; N, 16 . 8 . 
C, 57.1; I-I, 7.2; N, 16.7%). \J 3372, 3180 (NH str), 
max 
1673, 1644 (acetate C=O and amide). P.m.r. c5(CDC1 3 ) 
1.93-3.57 (m's, 6H, methylene protons), 2.35 (s, 3H, 
acetyl CH 3 )m 7,40 (br s, 2H, CONH 2 ), 11.7 (br s, lH, NHAc). 
Ethyl 2-oxocyclopentylglyoxylate (3.34) 
A solution of sodium ethoxide was prepared by the 
cautious addition of clean sodium (23 g, 1 gm atom) to 
anhydrous ethanol (300 ml) in a 1 litre three knecked 
round bottom flask with a dropping funnel, oil sealed· 
stirrer and reflux condenser carrying a calcium chloride 
drying tube. The solution was cooled to 10° and an 
ice-cold mixture of cyclopentanone (84 g, 1 mmol) and 
ethyl oxalate (146 g, 1 rnmol) added over a period of 15 min. 
Vigorous stirring was maintained throughout the addition, 
I 
163. 
for 1 hat ice-bath temperature and for 5 hat room 
temperature. The mixture was carefully decomposed with 
cold dilute sulphuric acid (28 ml cone. sulphuric acid and 
220 gm ice) keeping the internal temperature at 5-lo 0 c. 
The solution was diluted with cold water to a volume of 2L. 
and the supernatant decanted from the precipitated product. 
The aqueous part was extracted with benzene (4 x 250 ml) 
and the extracts combined with the precipitate. The 
extracts were washed with water (2 x 100 ml), dried (Mgso 4 ) 
and evaporated to afford the crude product. Distillation 
gave the ethyl glyoxylate (157 . 4 g, 85%), b.p. 156-158°, 
17 rnrnHg , m.p. 30-31° (lit. 156 b.p. 138-139°, 14 rnrnHg, oil, 
13% yield; lit . 157 m.p. 26-27° from sodium ethoxide in 
ether) . 
1 . 9 3 - 3 . 3 3 ( m , 6 H , rn et h y 1 en e protons ) , 4 . 5 9 ( q , 2 H , -OCH 2 rn 3) , 
12 . 4 (br s, lH, OH) . 
3-Ethoxycarbonyl-trimethylene-4,5-pyrazole (3.38) and 
5, 6·-trimethylene-4-oxypyridazin-3-one ( 3. 39) 
(a) Ethyl 2-oxocyclopentylglyoxylate (4.7 g, 2.5 n;unol) 
was dissolved in hot 30% aqueous ethanol (30 ml). Hydrazine 
hydrate (1.5 ml) was then added and the mixture heate d under 
reflux for 1 h. The solution was cooled and the precipitate 
was collected and recrystallized from benzene to afford the 
0 . 154 0 pyrazole (2 . 6 g, 57%), m. p. 122-123 (lit. 124-125 ) . 
v 1730 (ester C=O). 
max 
P.m.r. c5(CDC1 3 ) 1.33 (t, 3H, 
-OCH 2cH3 ), 2.23-3 . 00 (m, 6H, methylene protons), 4.37 
( q , 2 H , - OCH 2 CH 3 ) , 12 . 3 7 ( b r s , 1 H , NH) . Evaporation of 
the filtrate and recrystalljzation from ethanol afforded 
the pyridazinone (1.1 g, 28.9%) m.p. 257-259° (lit. 158 
254-256°) . v 3320, 3250 (OH and NH str), 1665, 1608 
max 
(amide, and C=N). 
(b) The ester (1.84 g, 10 mmol), hydrazine hydrate 
(0.6 g) and 95% ethanol (10 ml) wer~ heated under reflux 
for 30 minutes. The mixture was cooled and the crystals 
164. 
collected. Two further crops were obtained by evaporation 
of the filtrates to a small volume. The combined product 
(1.28 g, 84%) was recrystallized from ethanol to afford 
the pyridazinone melting at 257-259° and identical with 
that described in (a). 
I, 
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BIOLOGICAL EVALUATION OF TETRODOTOXIN 
AND SnXITOXIN ANALOGUES 
1) Introduction 
Tetrodotoxin and saxitoxin have proved to be 
valuable tools in neurophysiology, and have yielded 
important information about the sodium channels of 
excitable membranes. Studies of the structure-
activity relationships of each toxin are potentially 
useful in elucidating the mechanisms of action and 
nature of binding at the sodium channel, and could 
lead to the design of potent new drugs. However, 
h . 1 d 159 . d'f' as as been previous y note , even minor mo i ic-
ations of the tetrodotoxin molecule result in an 
almost complete loss of biological activity, 4 and a 
direct approach by modification of the structure of 
165. 
the toxins and observation of the biological activities 
of the analogues would appear to be unproductive. The 
presence of the guanidinium moiety would seem to be 
essential for the pharmacological actions of the toxins. 
Kao and Nishiyama 1 were first to make the now generally 
accepted suggestion that the guanidinium group found in 
both toxins enters the sodium channel where it becomes 
"stuck" because the remainder of the molecule is too 
bulky to pass through. Thus, an alternative approach 
to structure-activity studies is the synthesis and 
----, 
I 
I 
L 
166. 
evaluation of cyclic guanidinium and urea analogues o f 
the toxins. Compounds of these types were selected 
because in common with the toxins, they contain a cyclic 
guanidinium group, although they are otherwise 
structurally different. 
The most suitable preliminary method for evaluating 
the activity of the analogues was to determine their 
minimum lethal doses (M.L.D.) . . in mice. The analogues 
were administered to mice by intraperitoneal injection 
as emulsions or solutions in 0.9N sterile saline. The 
analgesic and local anaesthetic properties of some 
compounds were investigated by treating mice with 
sub-lethal doses of the compound. Fifteen minutes later 
the mice were challenged with 0.5 % acetic acid and 
observed for writhing normally resultant from such a 
challenge. When no writhing was observed the compound 
was judged as having analgesic or local anaesthetic 
effects. The mode of death, death time and other 
macroscopic effects yielded useful information about the 
injected compounds and gave some indication of their 
site of action. 
2) Tetrodotoxin analogues 
The tetrodotoxin molecule has been described in 
steric terms as being spherical in shape with a 
protruding tongue - the guanidinium group. 2-0xo- and 
2-imino-adamantanopyrimidines incorporating a spherical 
non-penetrating hydrocarbon moiety and a protruding 
hydrophilic "tongue" were prepared in an effort to 
duplicate the shape of the tetrodotoxin molecule. 
lb '/. 
. .. 
The known biological act ~vity of adamantane derivatives 
was a further consideration in the design of these 
analogues. Since the initial reports of the antiviral 
. 160-166 
activity of 1-aminoadamantane hundreds of other 
adamantane derivatives have been s6reened for antiviral, 
. 
antiinflammatory, antitumor, insecticidal, analgesic and 
# 
other activities . Several reviews on the biological 
activity of adamantane-containing drugs have appeared 
167-169 in recent years . With some exceptions, the 
adamantane moiety has been used primarily to modify 
the potency of substances already recognised as drugs. 
The adamantane substituent increases the lipophilic 
character of these substances and hence enables them to 
be more easily transported through membranes. The 
adamantane moiety is not metabolized in man and therefore 
has the capacity to persist as an effective drug in a 
biological system. In 1969, Chakrabarti and coworkers 56 
described the preparation of tetrahydroadamantano[2,1-d]-
pyrimidin-2(1H)-one (2.31) and derivatives and claimed 
them to be useful as analgesics and local anaesthetics. 
The minimum lethal doses of the tetrodotoxin 
analogues which were synthesized ( see sections 3 and 
4) are listed in Table 4.1. Although the 
2-iminoadamantanopyrimidines were considerably less 
toxic than tetrodotoxin, their toxicities were 
nevertheless comparable with those of the most active 
1 . .d. k 49,51,159 eye ic guani ines nown. 
I 
I 
1G8. 
Table 4.1 
~ETR0D0TOX1N hNALOGUES 
Minimum lethal doses for male mice 
Compound Approximate 
M. L . D . ( mg/kg) 
2-aminotetrahydroadamantano[2,1-d]pyrimidine 
sulphate (2.30)* 246 
tetrahydroadamantano[2,1-d]pyrimidin-2(1H)-one 
(2.31)* t 300 
dihydroadamantano[2,1-d]pyrimidin-2,4(1ll,3H)-
dione (2.33)*t 
adamantan-l-ylguanidine.Hc1113 
170 N-[adamantan-1-yl]-urea*t 
5-hydroxytetrahydroadamantano[l,2-d]pyrimidin -
2-iminium bromide (2.60) 
adamantano[2,l-e]triazin -2-one (2.61)* 
trans -2-amino-3,4,4a,5,6,7,8,8a- 51 
octahydroguinazoline hydrochloride 
cis -2-amino-3-methyl-3,4,4a,5,6,7,8,8a-
octahydroquinazoline51 
cis -Ba-methoxycarbonyl methyl-2-amino- 51 3,4,4a,5,6,7,8,8a-octahydroquinazoline 
cis -3-methylperhydroquinazolin-2-one 51 
d . 51 tetra otoxin 
76 
'vl80 
>750 
125 
>750 
110 
90 
210 
75 
0.013 
* Administered as an emulsion in Tween 80~0.9N sterile 
saline (1:9). 
t Exhibited analgesic and local anaesthetic properties. 
I 
I 
I 
/, 
Paralysis of the hi t1d limbs was apparent soon 
after injection and death occurred within 1-10 minutes 
by respiratory paralysis. The macroscopic effects of 
the analogues appear to be qualitatively similar to 
those of tetrodotoxin. The oxo-compound (2.31) was 
. 
of comparable toxicity to the amino-compound (2.30), 
but the dioxo-compound (2.33) was considerably more 
toxic. However, the oxo- and dioxo- derivatives 
killed the mice by affecting the central nervous system, 
causing severe convulsions and pain.* Mice treated 
with sub-lethal doses of the oxo- and dioxo- compounds 
were challenged with an intraperitoneal injection of 
0.5% acetic acid and observed for writhing normally 
resultant from such a challenge. The mice were 
completely protected from writhing and the compounds 
were judged to possess analgesic and local anaesthetic 
properties. The triazine-one (2.61) was apparently 
inactive, the mice being unaffected by doses of 
750 mg/kg or less. d 1 1 . d. 113 d A amantan- -y guani ine an 
17 0 · N-[adamantan-1-yl]-urea were prepared for compa~ison 
with the cyclic guanidine and urea analogues. The 
guanidino compound had a toxicity comparable 
of 
in 
at 
* 
the cyclic guanidino compounds and killed 
the same way. N-[Adamantan-1-yl]-urea 
the levels administered (<750 mg/kg) . 
Similar effects were observed with 171 
cis-3 -methylperhydroquinazolin-2-one. 
was 
It 
with that 
the mice 
nontoxic 
was 
II 
I 
1 '/ 0. 
'L' et l) 1 c ~ . 2 
l\MINO-I\01\Ml\N'l '/\N t :S t 
Minimum l e thal doses in male mice 
Approximate 
Compound 
M.L.D. (mg/kg) 
2-aminoadamantan-1-ol . HCl 260 
2-oxoadamantane-1-ylamine.HCl 540 
1-aminoadamantane . HBr* 295 
t Potential antiviral and anti-Parkinsonian agents. 
* A known antiviral and anti-Parkinsonian agent. 
II 
I 
effective as a local anaesthetic and analgesic, but 
appeared to cause long term central nervous system 
damage. The latter was deduced from the behaviour 
of test animals four or more hours after injection. 
They were sedate, their movements were uncoordinated 
and the mice did not appear to recover from the 
effects of the compound. 
Several amino-adamantanes (potential antiviral 
agents or antidepressants) were tested and showed 
varying degrees of toxicity (see Table 4.2). The 
compounds caused central nervous damage in those 
mice that survived large doses, otherwise the mice 
suffered prolonged convulsions followed by death. 
3) Saxitoxin Analogues 
A limited number of compounds were examined and 
the minimum lethal doses for the saxitoxin analogues 
are illustrated in Table 4.3. The imidazolone (3.16) 
·and its ring-opened analogue (3.21) were nontoxic at 
doses below 500 mg/kg although the_ imidazolone did 
induce mild convulsions. 1,3-Diguanidinopropane 
sulphate killed mice by respiratory inhibition and 
mice which survived were sedate for long periods. 
These results should be compared with those of the 
52 
simple analogues prepared by Armarego and Reece 
(see Table 4.3). 
171. 
, ' 
Table 4.3 
SAXITOXIN ANALOGUES 
Minimum lethal doses for male mice 
Compound 
4(5)-aminoimidazol-2(3H)-one (3.16) 
a -ureidoacetamide (3.21) 
1,3-diguanidinopropane sulphate* 
N-methylguanidine.HCl 
2-amino-4,4a,5,6,7,8,8a-hexah~dro-3H-
cyclopenta[d]pyrimidine5 
2-amino-4,5-dihydroimidazole52 
* 
172. 
Approximate 
M.L.D. (mg/kg) 
>750 
>500 
350 
600 
170 
120 
See Part 3, Section 2 (iii) Experimental. 
I I, 
I 
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From these observat i. ons it may be concluded 
that the guanidinium moiety has a significant part 
to play in the saxitoxin- and tetrodotoxin- like 
activity of the analogues described above. The 
analogues incorporating cyclic guanidinium moieties 
are considerably less toxic than tetrodotoxin but 
have the same mode of action, and it can therefore 
be concluded that the polar groups of tetrodotoxin 
are essential for its extreme toxicity. The 
spherical shape of the adamantane moiety does not 
appear to enhance the activity of the analogues 
although some possess analgesic and local anaesthetic 
properties. 
l'lJ. 
II 
I 
I, 
/ , 
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